UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 

FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 29, 2019 (May 22, 2019)
 

Emerald Expositions Events, Inc.
(Exact name of registrant as specified in its charter)
 

 
 
 
 
 
 
Delaware
 
001-38076
 
42-1775077
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
 
31910 Del Obispo Street
Suite 200
San Juan Capistrano, California
 
92675
 
 
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (949) 226-5700
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4c)
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b-2).
 
Emerging Growth Company    
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    
 
Securities registered pursuant to Section 12(b) of the Act: 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.01 per share
 
EEX
 
New York Stock Exchange




Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 

Appointment of Brian Field as Chief Operating Officer  

On May 22, 2019, the Board of Directors (the “ Board ”) of Emerald Expositions Events, Inc. (the “ Company ”) appointed Brian Field as Chief Operating Officer of the Company and its subsidiaries, effective June 1, 2019.

 Mr. Field, 51, brings more than 20 years of experience, including the last five years as Chief Operating Officer of UBM Americas, a division of UBM plc, now part of Informa plc, a U.K.-based multinational events, academic publishing and business intelligence business, where Mr. Field had responsibilities over sales, marketing operations, data services, and creative services.   Mr. Field has deep experience in B2B and B2C industries, including in healthcare information, life sciences, digital media and expositions.   Prior to UBM Americas, he served two years as Managing Director of the healthcare/life-sciences division of that business, UBM Medica, and, prior to that, one year as SVP of Product and Operations.   Earlier in his career, Mr. Field held senior positions in operations, product development, marketing and strategy development, serving as acting COO of the New Products Group of Turner Broadcasting, Inc, and as a senior marketing strategist in a division of Omnicom.

 Mr. Field holds a bachelor’s degree from Connecticut College, a master’s degree from The Juilliard School, and a doctorate degree from Columbia University, and has served on the faculty of American University’s Kogod School of Business.

 There are no related person transactions (or proposed related person transactions) with respect to Mr. Field reportable under Item 5.02(c) of Form 8-K and Item 404(a) of Regulation S-K since the beginning of the Company’s last fiscal year.   There are no family relationships to disclose with respect to Mr. Field reportable under Item 401(d) of Regulation S-K.

 Mr. Field will enter into the Company’s standard form of indemnification agreement, pursuant to which the Company agrees to indemnify its directors and officers to the fullest extent permitted by applicable law and, subject to certain conditions, to advance expenses in connection with proceedings as described in the indemnification agreement.

Field Employment Agreement

In connection with Mr. Field’s appointment as Chief Operating Officer, on May 22, 2019, the Compensation Committee (the “ Compensation Committee ”) of the Board approved an Employment Agreement by and among Emerald Expositions, LLC (“ Emerald ”), Mr. Field, and, solely for the purposes of Sections 2.3 and 8.1 thereof, the Company, effective June 1, 2019 (the “ Field Employment Agreement ”).  The following description is intended to be a summary and not a full description of all of the terms of the Field Employment Agreement, which is incorporated herein by reference. A copy of the Field Employment Agreement is attached as Exhibit 10.1 to this Current Report on Form 8-K.

The Field Employment Agreement provides for an indefinite term, subject to the termination provisions of the Field Employment Agreement summarized below. It entitles Mr. Field to (a) an annual base salary of $350,000; (b) an annual bonus, with a target annual bonus equal to $200,000, subject to satisfaction of performance goals set annually by the Company’s Chief Executive Officer; (c) eligibility to participate in all benefits programs for which other senior executives of Emerald are generally eligible; (d) eligibility to take an unlimited number of vacation days, pursuant to Emerald’s MyTime policy; (e) reimbursement for reasonable, documented business expenses; and (f) perquisites in the form of (i) business class travel on flights approximately two hours or longer; and (ii) reimbursement up to $15,000 for reasonable, documented legal fees incurred in connection with the drafting, negotiation and execution of the Field Employment Agreement.
In the event of a termination of employment for any reason, Mr. Field shall be entitled to payment of any earned but unpaid base salary, vested benefits in accordance with the applicable employee benefit plan, unreimbursed business expenses, unreimbursed legal fees and (except in the case of a termination by Emerald for cause, by Mr. Field without good reason, other than due to death or disability (each as defined in the Field Employment Agreement)) earned but unpaid annual bonus for calendar years completed prior to the termination date.
In addition, upon a termination of employment other than for cause, death, or disability, or upon a termination for good reason, and subject to the execution and non-revocation of a general release of claims against the Company and Emerald, Mr. Field shall be entitled to receive: (x) an amount equal to one times the sum of annual base salary and the annual bonus actually paid to Mr. Field for the previous calendar year, paid in equal installments over 12 months; and (y) subject to the timely election of continuation coverage under COBRA and Mr. Field’s copayment of premiums associated with such coverage consistent with amounts paid by Mr. Field during the year of termination, monthly reimbursement of the excess costs of continued health benefits for himself and his covered dependents for the twelve month period following the date of termination. Upon a termination of employment due to his death or disability, Mr. Field is entitled to receive a cash amount equal to his pro-rata bonus for the year of termination, based on the actual performance of the Company for the full year.
Mr. Field is subject to a perpetual confidentiality covenant and, during his employment with Emerald and for 12 months immediately thereafter, non-solicitation, non-competition and non-disparagement covenants.
The Field Employment Agreement also entitles Mr. Field to receive an initial equity grant, pursuant to the Company’s 2017 Omnibus Equity Plan (the “ Plan ”). His initial grant shall consist of a combination of restricted stock units (“ RSUs ”) and an option to purchase common stock of the Company (an “ Option ”), and have an aggregate value of $350,000 on the date of grant, which is expected to be June 3, 2019. For future years, Mr. Field will be eligible to receive equity grants commensurate with his position, as determined by the Compensation Committee and the Company’s Chief Executive Officer . On May 22, 2019, the Compensation Committee approved the following awards to Mr. Field, which are expected to be entered into on June 3, 2019: (a) a number of RSUs with an aggregate value equal to $245,000, subject to his execution of a Restricted Stock Unit Award Agreement (the “ RSU Award Agreement ”), and (b) an Option with a Black-Scholes value equal to $105,000, subject to his execution of a Stock Option Agreement (the “ Stock Option Agreement ”). The forms of the RSU Award Agreement and Stock Option Agreement are incorporated herein by reference, and copies thereof are attached as Exhibits 10.2 and 10.3, respectively, to this Current Report on Form 8-K.
Mr. Field shall also be entitled to receive an additional one-time performance-based share award under the Plan, with a total award value of up to $2,870,000 and vesting linked to the Company’s achievement of certain sustained share prices during Mr. Field’s employment, the terms of which are summarized immediately below.
Field Performance Equity Grant
On May 22, 2019, the Compensation Committee approved a Performance Based Share Award Agreement, by and between the Company and Mr. Field, which is expected to be entered into on June 3, 2019   (the “ Performance Award Agreement ”), pursuant to which Mr. Field shall be entitled to receive a one-time performance-based share award under the Plan (the “ Performance Award ”). The following description is intended to be a summary and not a full description of all of the terms of the Performance Award Agreement, which is incorporated herein by reference. A copy of the form of Performance Award Agreement is attached as Exhibit 10.4 to this Current Report on Form 8-K.
The Performance Award Agreement provides that Mr. Field’s right to receive shares in settlement of the Performance Award shall vest based upon achievement of the closing share prices as set forth in the schedule below for a period of at least sixty out of the preceding ninety trading days (each such share price a “ Vesting Threshold ”).  Upon achievement of each relevant Vesting Threshold, Mr. Field shall be issued a number of shares equal to the corresponding award value identified in the schedule below, divided by the closing price per share on the trading day upon which the relevant Vesting Threshold was satisfied.

60/90 Trading Day Closing Share Price
(Vesting Thresholds)
Award Value
At least $18.00 per Share
$410,000
At least $20.00 per Share
$615,000
At least $22.00 per Share
$820,000
At least $24.00 per Share
$1,025,000

In the event of a change in control, if the price per share paid by the buyer is greater than any of the Vesting Thresholds above (to the extent still unsatisfied), such portion of the Performance Award shall vest upon the closing of such change in control by treating such price per share paid by the buyer as having satisfied the applicable Vesting Threshold(s), and any remaining unvested portion of the Performance Award shall be forfeited as of the closing of such change in control.
In the event of a termination of employment for any reason, the unvested portion of the Performance Award shall terminate, except that upon a termination of employment other than for cause, or upon a termination for good reason within three months prior to the earlier of the execution of an agreement resulting in a change in control or the date of a change in control, any unvested shares subject to the Performance Award shall remain eligible to vest in accordance with the Performance Award Agreement’s vesting conditions, including in the event of a change in control. Upon a termination for cause, both vested and unvested portions of the Performance Award shall be immediately and automatically forfeited for no consideration.
The Performance Award Agreement provides that Mr. Field shall not sell, transfer, assign, pledge or otherwise encumber or dispose of any shares issued upon settlement of any portion of the Performance Award prior to the first to occur of (i) one year following the applicable settlement date, and (ii) the occurrence of a change in control.

Item 7.01
Regulation FD Disclosure .
 
On May 22, 2019, the Company issued a press release announcing the appointment of Brian Field as Chief Operating Officer .

The press release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein.

Item 9.01
Financial Statements and Exhibits .

(d) Exhibits.

Exhibit No.
Description
   
   
   
   


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
Date: May 29, 2019
 
 
 
 
 
EMERALD EXPOSITIONS EVENTS, INC.
       
 
 
 
 
 
 
 
 
By:
 
/s/ David Gosling
 
 
 
 
 
 
David Gosling
 
 
 
 
 
 
Senior Vice President, General Counsel and Secretary
 
Exhibit 10.1





EMPLOYMENT AGREEMENT
EMPLOYMENT AGREEMENT, dated as of May 22, 2019 (this “ Agreement ”), by and between Emerald Expositions, LLC, a Delaware limited liability company (the “ Company ”), and Brian Field (the “ Executive ”) (each of the Executive and the Company, a “ Party ,” and collectively, the “ Parties ”) and, solely for purposes of Sections 2.3 and 8.1, Emerald Expositions Events, Inc., a Delaware corporation (“ Parent ”).
WHEREAS, the Company desires to employ the Executive as Chief Operating Officer of the Company and wishes to acquire and be assured of the Executive’s services on the terms and conditions hereinafter set forth; and
WHEREAS, the Executive desires to be employed by the Company as Chief Operating Officer and to perform and to serve the Company on the terms and conditions hereinafter set forth.
NOW, THEREFORE, in consideration of the mutual covenants contained herein and other valid consideration, the sufficiency of which is acknowledged, the Parties hereto agree as follows:
Section 1.              E mployment .
1.1.   Term Subject to Section 3 hereof, the Company agrees to employ the Executive, and the Executive agrees to be employed by the Company, in each case pursuant to this Agreement, for a period commencing on June 1, 2019 (the “ Effective Date ”) and ending on the date of the termination of the Executive’s employment in accordance with the terms hereof.  The Executive’s period of employment pursuant to this Agreement shall hereinafter be referred to as the “ Employment Period .”
1.2.   Duties During the Employment Period, the Executive shall serve as the Company’s Chief Operating Officer and in such other positions as an officer or director of the Company and such Affiliates (as defined in Section 8.12 below) of the Company as the Executive and the board of directors of Parent (the “ Board ”) shall mutually agree from time to time, and shall report directly to the Chief Executive Officer .  In the Executive’s position as Chief Operating Officer , the Executive shall perform such duties, functions and responsibilities during the Employment Period as are commensurate with such position, as reasonably and lawfully directed by the Chief Executive Officer.  The Executive’s principal place of employment shall be the Company’s offices in New York, New York and White Plains, New York.
1.3. Exclusivity During the Employment Period, the Executive shall devote substantially all of the Executive’s business time and attention to the business and affairs of the Company, shall faithfully serve the Company, and shall conform to and comply with the lawful and reasonable directions and instructions given to the Executive by the Board, consistent with Section 1.2 hereof.  During the Employment Period, the Executive shall use the Executive’s best efforts to promote and serve the interests of the Company and shall not engage in any other business activity, whether or not such activity shall be engaged in for pecuniary profit; provided that the Executive may (a) serve any civic, charitable, educational or professional organization and (b) manage the Executive’s personal investments, in each case so long as any such activities do not (X) violate the terms of this Agreement (including Section 4) or (Y) interfere with the Executive’s duties and responsibilities to the Company.
Section 2.              C ompensation .
2.1.   Salary As compensation for the performance of the Executive’s services hereunder, during the Employment Period, the Company shall pay to the Executive a salary at an annual rate of $ 350,000 , payable in accordance with the Company’s standard payroll policies (the “ Base Salary ”).
2.2.   Annual Bonus For each calendar year ending during the Employment Period, the Executive shall be eligible to receive an annual bonus (the “ Annual Bonus ”) to be based upon Company performance and other criteria for each such calendar year as determined by the Board.  The Executive’s target Annual Bonus opportunity for each calendar year that ends during the Employment Period shall be $200,000 (the “ Target Annual Bonus Opportunity ”).  The amount of the Annual Bonus actually paid shall depend on the extent to which the performance goals, set annually by the Board, are achieved or exceeded.  For calendar year 2019, however, in no event shall the Annual Bonus be less than $116,666.67.  The Annual Bonus shall be paid in the calendar year following the calendar year in respect of which it is earned at the same time as the Company normally pays bonuses to other senior executives; provided, that, if Executive’s employment hereunder is terminated prior to the Annual Bonus payment date (a) by the Company for Cause or (b) by the Executive voluntarily without Good Reason and not for death or Disability, the Annual Bonus shall not be payable.
2.3.   Equity The Executive shall be provided the following equity incentive interests and/or rights to purchase equity interests in the Parent:
      (a)   Initial Equity Grant On or as soon as practicable following the Effective Date, Parent shall grant to the Executive a combination of restricted stock units (“ RSUs ”) and an option to purchase common stock of Parent (an “ Option ”), pursuant to Parent’s 2017 Omnibus Equity Plan.  For calendar year 2019, the RSUs and Option shall have an aggregate value of $350,000 on the date of grant, allocated 70% to the RSUs and 30%  to the Option, with the Option valued based on its Black-Scholes value and RSUs valued based on the present market value of the underlying common stock of Parent, in each case as of the date of grant.
      (b) Subsequent Annual Equity Grants .  For future years, the Executive will be eligible to receive equity grants commensurate with his position, as determined by the Compensation Committee of Parent.
      (c)   One-Time Performance Equity Grant On or as soon as practicable following the Effective Date, the Executive shall receive an additional one-time performance based share award with vesting linked to the Company’s achievement of certain stock prices during the Employment Period, pursuant to the Equity Plan and a performance based share award agreement, substantially in the form attached hereto as Exhibit A.
2.4.   Employee Benefits During the Employment Period, the Executive shall be eligible to participate in such health and other group insurance and other employee benefit plans and programs of the Company as in effect from time to time on the same basis as other senior executives of the Company.
2.5.   Vacation During the Employment Period, the Executive shall be entitled to an unlimited number of vacation days, pursuant to the Company’s MyTime policy .
2.6. Business Expenses The Company shall pay or reimburse the Executive, upon presentation of documentation, for all commercially reasonable business out-of-pocket expenses that the Executive incurs during the Employment Period in performing the Executive’s duties under this Agreement in accordance with the expense reimbursement policy of the Company as approved by the Board (or a committee thereof), as in effect from time to time.  To the extent that any travel requires a flight approximately two hours or longer, the Executive shall be permitted to fly business class.  Notwithstanding anything herein to the contrary or otherwise, except to the extent any expense or reimbursement described in this Agreement does not constitute a “deferral of compensation” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and the regulations and guidance thereunder (“ Section 409A ”), any expense or reimbursement described in this Agreement shall meet the following requirements: (a) the amount of expenses eligible for reimbursement provided to the Executive during any calendar year will not affect the amount of expenses eligible for reimbursement to the Executive in any other calendar year; (b) the reimbursements for expenses for which the Executive is entitled to be reimbursed shall be made on or before the last day of the calendar quarter following the calendar quarter in which the applicable expense is incurred; (c) the right to payment or reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit; and (d) the reimbursements shall be made pursuant to objectively determinable and nondiscretionary Company policies and procedures regarding such reimbursement of expenses.
2.7.   Legal Fees The Company shall reimburse the Executive up to $15,000 for reasonable, documented legal fees and related expenses incurred in connection with the drafting, negotiation and execution of this Agreement.
Section 3.              Employment Termination .
3.1. Termination of Employment The Company may terminate the Executive’s employment hereunder for any reason, and the Executive may voluntarily terminate the Executive’s employment hereunder for any reason at any time upon not less than 15 days’ notice to the Company (the date on which the Executive’s employment terminates for any reason is herein referred to as the “ Termination Date ”).  Upon the termination of the Executive’s employment with the Company for any reason, the Executive shall be entitled to (a) payment of any Base Salary earned but unpaid through the Termination Date, (b) earned but unpaid Annual Bonus for calendar years completed prior to the Termination Date (payable in the ordinary course pursuant to Section 2.2), (c) vested benefits (if any) in accordance with the applicable terms of applicable Company arrangements and (d) any unreimbursed expenses in accordance with Sections 2.6 and 2.7 hereof (collectively, the “ Accrued Amounts ”).
3.2.   Certain Terminations .
      (a)   Termination by the Company other than for Cause, Death or Disability; Termination by the Executive for Good Reason If the Executive’s employment is terminated (X) by the Company other than for Cause, death or Disability or (Y) by the Executive for Good Reason, in addition to the Accrued Amounts, the Executive shall be entitled to: (i) a payment equal to one times the sum of the Executive’s Base Salary at the rate in effect immediately prior to the Termination Date and the Annual Bonus actually paid to the Executive for the previous calendar year (or the Target Annual Bonus Opportunity if the Termination Date occurs prior to the payment of the first Annual Bonus) (the “ Severance Amount ”); (ii) payment of the Pro-Rata Bonus (as defined below), payable at the time when annual bonuses are paid generally and (ii) subject to the timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“ COBRA ”) and the Executive’s copayment of premiums associated with such coverage consistent with amounts paid by the Executive during the year in which the Termination Date occurs, the Company shall reimburse the Executive, on a monthly basis, for the excess costs of continued health benefits for himself and his covered dependents for the twelve-month period following the Termination Date, or such earlier date on which COBRA coverage for the Executive and his covered dependents terminates in accordance with COBRA (“ Medical Benefit Continuation ”).
The Company’s obligations to pay the Severance Amount and the Pro-Rata Bonus and to provide Medical Benefit Continuation shall be conditioned upon (i) the Executive’s continued compliance with the Executive’s obligations under Section 4 of this Agreement and (ii) the Executive executing and delivering to the Company a general release in the form attached hereto as Exhibit B (the “ Release ”) and the Release becoming irrevocable within 30 days following the Termination Date (the date that the Release becomes irrevocable, the “ Release Effective Date ”).  Payment of the Severance Amount will be made in equal installments on the Company’s payroll dates occurring in the 12 month period following the Release Effective Date, and payments of the Medical Benefit Continuation will be paid, in each case commencing on the first payroll date of the Company following the Release Effective Date; provided , that , if the 30-day period referred to in the preceding sentence spans two calendar years, payments shall in all cases be paid or commence to be paid on the first payroll date in the second calendar year; provided , further, that, the first payment will include any installments that would have been paid prior thereto but for this sentence.
If the Executive is not permitted to continue participation in the Company’s medical insurance plan pursuant to the terms of such plan or pursuant to a determination by the Company’s insurance providers or such continued participation in any plan would result in the imposition of an excise tax on the Company pursuant to Section 4980D of the Code, the Company shall use reasonable efforts to obtain individual insurance policies providing medical benefits to the Executive and his covered dependents during the Medical Benefits Continuation period, but shall be required to pay for such policies only an amount equal to the amount the Company would have paid had the Executive continued participation in the Company’s medical plans; provided , that, if such coverage cannot be obtained, the Company shall pay to the Executive monthly during the Medical Benefit Continuation period an amount equal to the amount the Company would have paid had the Executive continued participation in the Company’s medical plan.
      (b)   Termination by Death or Disability If the Executive’s employment is terminated by reason of the Executive’s death or Disability, the Company shall pay the Executive (or the Executive’s heirs upon a termination by death) a pro-rata bonus for the year of termination, equal to the Annual Bonus the Executive would have been entitled to receive had the Executive’s employment not been terminated, based on the actual performance of the Company for the full year, multiplied by a fraction, the numerator of which is the number of days the Executive is employed by the Company during the applicable year prior to and including the Termination Date and the denominator of which is 365 (the “ Pro-Rata Bonus ”), payable at the time when annual bonuses are paid generally.
      (c)   Definitions For purposes of Section 3, the following terms have the following meanings:
   (1)   Cause shall mean the Executive’s having engaged in any of the following: (A) willful misconduct or gross negligence in the performance of any of the Executive’s duties to the Company, which, if capable of being cured, is not cured to the reasonable satisfaction of the Board within 30 days after the Executive receives from the Board written notice of such willful misconduct or gross negligence; (B) intentional failure or refusal to perform reasonably assigned duties by the Board or to cooperate with an internal investigation being conducted by or at the direction of the Board, which is not cured to the reasonable satisfaction of the Board within 30 days after the Executive receives from the Board written notice of such failure or refusal; (C) any indictment for, conviction of, or plea of guilty or nolo contendere to, (1) any felony (other than motor vehicle offenses the effect of which do not materially affect the performance of the Executive’s duties) or (2) any crime (whether or not a felony) involving fraud, theft, breach of trust or similar acts, whether of the United States or any state thereof or any similar foreign law to which the Executive may be subject; (D) any willful failure to comply with any written rules, regulations, policies or procedures of the Company which, if not complied with, would reasonably be expected to have a material adverse effect on the business or financial condition of the Company, which in the case of a failure that is capable of being cured, is not cured to the reasonable satisfaction of the Board within 30 days after the Executive receives from the Company written notice of such failure or (E) abuse of alcohol or another controlled substance.  If the Company terminates the Executive’s employment for Cause, the Company shall provide written notice to the Executive of that fact on or before the termination of employment.However, if, within 60 days following the termination, the Company first discovers facts that would have established “Cause” for termination, and those facts were not known by the Company at the time of the termination, then the Company may provide Executive with written notice, including the facts establishing that the purported “Cause” was not known at the time of the termination, in which case the Executive’s termination of employment will be considered a for Cause termination under this Agreement, and Executive shall be required to immediately return to the Company all amounts previously paid or provided to the Executive pursuant to Section 3.2(a), and the Company shall have the right to cease to pay or provide any future amounts pursuant to Section 3.2(a).
   (2)   Disability shall mean the Executive is entitled to and has begun to receive long-term disability benefits under the long-term disability plan of the Company in which the Executive participates, or, if there is no such plan, the Executive’s inability, due to physical or mental illness, to perform the essential functions of the Executive’s job, with or without a reasonable accommodation, for 180 days out of any 270 day consecutive day period.
   (3)   Good Reason shall mean one of the following has occurred: (A) a material breach by the Company of any of the covenants in this Agreement; (B) any reduction in the Executive’s Base Salary or bonus opportunity; (C) the relocation of the Executive’s principal place of employment that would increase the Executive’s one-way commute by more than 20 miles; or (D) any material and adverse change in the Executive’s position, title or status or any change in the Executive’s job duties, authority or responsibilities to those of lesser status.  A termination of employment by the Executive for Good Reason shall be effectuated by giving the Company written notice of the termination, setting forth the conduct of the Company that constitutes Good Reason, within 30   days of the first date on which the Executive has knowledge of such conduct.The Executive shall further provide the Company at least 30 days following the date on which such notice is provided to cure such conduct.  Failing such cure, a termination of employment by the Executive for Good Reason shall be effective on the day following the expiration of such cure period.
     (d)   Section 409A If the Executive is a “specified employee” for purposes of Section 409A, to the extent the Severance Amount required to be paid pursuant to Section 3.2 hereof constitutes “non-qualified deferred compensation” for purposes of Section 409A, payment thereof shall be delayed until the day after the first to occur of (i) the day which is six months from the Termination Date and (ii) the date of the Executive’s death, with any delayed amounts being paid in a lump sum on such date and any remaining payments being made in the normal course.  For purposes of this Agreement, the terms “terminate,” “terminated” and “termination” mean a termination of the Executive’s employment that constitutes a “separation from service” within the meaning of the default rules under Section 409A.  For purposes of Section 409A, the right to a series of installment payments under this Agreement shall be treated as a right to a series of separate payments.
3.3.   Exclusive Remedy The foregoing payments upon termination of the Executive’s employment shall constitute the exclusive severance payments and benefits due the Executive upon a termination of the Executive’s employment.
3.4.   Resignation from All Positions Upon the termination of the Executive’s employment with the Company for any reason, the Executive shall, if requested, resign as of the Termination Date, from all positions the Executive then holds as an officer, director and member of the boards of directors (and any committee thereof) of the Company and its Affiliates.  The Executive shall be required to execute such writings as are required to effectuate the foregoing .
3.5.   Cooperation Following the termination of the Executive’s employment with the Company for any reason, upon reasonable request from the Company and at the Company’s expense, the Executive shall respond and provide information with respect to matters in which Executive has knowledge as a result of his services to the Company and its subsidiaries, and will provide reasonable assistance to the Company in defense of any claims that may be made against the Company, and will assist the Company in the prosecution of any claims that may be made by the Company, to the extent that such claims may relate to the period of the Executive’s employment with the Company .
Section 4.              Unauthorized Disclosure; Non-Competition; Non-Solicitation; Interference with Business Relationships; Proprietary Rights .
4.1.   Unauthorized Disclosure The Executive agrees and understands that in the Executive’s position with the Company, the Executive will be exposed to and will receive information relating to the confidential affairs of the Company and its Affiliates, including, without limitation, technical information, intellectual property, business and marketing plans, strategies, customer information, software, other information concerning the products, promotions, development, financing, expansion plans, business policies and practices of the Company and its Affiliates and other forms of information considered by the Company and its Affiliates to be confidential or in the nature of trade secrets (including, without limitation, ideas, research and development, know-how, formulas, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information and business and marketing plans and proposals) (collectively, the “ Confidential Information ”).  Confidential Information shall not include information that is generally known to the public or within the relevant trade or industry other than due to the Executive’s violation of this Section 4.1 or disclosure by a third party who is known by the Executive to owe the Company an obligation of confidentiality with respect to such information.  The Executive agrees that at all times during the Executive’s employment with the Company and thereafter, the Executive shall not disclose such Confidential Information, either directly or indirectly, to any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof (each a “ Person ”) without the prior written consent of the Company and shall not use or attempt to use any such information in any manner other than in connection with the Executive’s employment with the Company, unless required or permitted by law to disclose such information, in which case the Executive shall provide the Company with written notice of such requirement as far in advance of such anticipated disclosure as reasonably practicable.  This confidentiality covenant has no temporal, geographical or territorial restriction.  Upon termination of the Executive’s employment with the Company, the Executive shall promptly supply to the Company all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data and any other tangible product or document which has been produced by, received by or otherwise submitted to the Executive during the Executive’s employment with the Company, and any copies thereof, in each case, to the extent remaining in the Executive’s (or capable of being reduced to the Executive’s) possession.  Notwithstanding the foregoing, nothing herein shall prevent the Executive from disclosing Confidential Information to the extent required by law.  Additionally, nothing herein shall preclude the Executive’s right to communicate, cooperate or file a complaint with any U.S. federal, state or local governmental or law enforcement branch, agency or entity (collectively, a “ Governmental Entity ”) with respect to possible violations of any U.S. federal, state or local law or regulation, or otherwise make disclosures to any Governmental Entity, in each case, that are protected under the whistleblower or similar provisions of any such law or regulation; provided that in each case such communications and disclosures are consistent with applicable law.  Nothing herein shall preclude the Executive’s right to receive an award from a Governmental Entity for information provided under any whistleblower or similar program.  The Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in confidence to a federal, state or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law.  The Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, provided that such filing is made under seal.  If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose the trade secret to the Executive’s attorney and use the trade secret information in any related court proceeding, provided that the Executive files any document containing the trade secret under seal and does not disclose the trade secret except pursuant to court order.
4.2.   Non-Competition By and in consideration of the Company entering into this Agreement, and in further consideration of the Executive’s exposure to the Confidential Information, the Executive agrees that the Executive shall not, during the Employment Period and for a period of 12 months after the Executive’s termination of employment for any reason (the “ Restriction Period ”), directly or indirectly, own, manage, operate, join, control, be employed by, or participate in the ownership, management, operation or control of, or be connected in any manner with, including, without limitation, holding any position as a stockholder, director, officer, consultant, independent contractor, employee, partner, or investor in, any Restricted Enterprise (as defined below); provided that in no event shall (X) ownership by the Executive of two percent or less of the outstanding securities of any class of any issuer whose securities are registered under the Securities Exchange Act of 1934, as amended, standing alone, be prohibited by this Section 4.2, so long as the Executive does not have, or exercise, any rights to manage or operate the business of such issuer other than rights as a shareholder thereof or (Y) being employed by an entity, standing alone, be prohibited by this Section 4.2, so long as the entity has more than one discrete and readily distinguishable part of its business and the Executive’s duties are not at or involving the part of the entity’s business that is actively engaged in a Restricted Enterprise.  For purposes of this paragraph, “ Restricted Enterprise ” shall mean any Person that is engaged, directly or indirectly, in a business which is in competition with a business of Parent or any of its subsidiaries as of the Termination Date in any country or territory in which Parent or any of its subsidiaries markets any of its services or products or has plans to begin marketing any of its services or products.  During the Restriction Period, upon request of the Company, the Executive shall notify the Company of the Executive’s then-current employment status .
4.3.   Non-Solicitation of Employees During the Restriction Period, the Executive shall not directly or indirectly hire, contact, induce or solicit (or assist any Person to hire, contact, induce or solicit) for employment any person who is, or within 12 months prior to the date of such hiring, contacting, inducing or solicitation was, an employee of the Company or any of its Affiliates; provided, however, that the foregoing shall not prevent the Executive from placing advertisements in publications of general circulation or on job search websites, so long as the Executive is not personally involved in recruiting any individual who responds to such an advertisement .
4.4.   Interference with Business Relationships During the Restriction Period (other than in connection with carrying out the Executive’s responsibilities for the Company and its Affiliates), the Executive shall not directly or indirectly induce or solicit (or assist any Person to induce or solicit) any customer or client of the Company or its subsidiaries to terminate its relationship or otherwise cease doing business in whole or in part with the Company or its Affiliates, or directly or indirectly interfere with (or assist any Person to interfere with) any material relationship between the Company or its Affiliates and any of its or their customers or clients so as to cause harm to the Company or its Affiliates .
4.5.   Extension of Restriction Period The Restriction Period shall be tolled for any period during which the Executive is in breach of any of Section 4.2, 4.3 or 4.4 hereof .
4.6.   Proprietary Rights Except to the extent any rights in any inventions, discoveries, and improvements (whether or not patentable or registrable under copyright or similar statutes), and all patentable or copyrightable works, initiated, conceived, discovered, reduced to practice, or made by the Executive, either alone or in conjunction with others, during the Executive’s employment with the Company and related to the business or activities of the Company and its Affiliates (the “ Developments ”) constitute a work made for hire under the U.S. Copyright Act, 17 U.S.C. § 101 et seq. that are owned ab initio by the Company and/or its applicable Affiliate, the Executive assigns and agrees to assign all of the Executive’s right, title and interest in all Developments (including all intellectual property rights therein) to the Company or its nominee without further compensation, including all rights or benefits therefor, including without limitation the right to sue and recover for past and future infringement.  The Executive acknowledges that any rights in any Developments constituting a work made for hire under the U.S. Copyright Act, 17 U.S.C § 101 et seq. are owned upon creation by the Company and/or its applicable Affiliate as the Executive’s employer.  The Executive hereby expressly and irrevocably waives any and all moral rights in the Developments including, without limitation, the right to attribution or anonymity in respect of authorship, the right to restrain any distortion, mutilation or other modification of any such Developments and the right to prohibit any use of any such Developments in association with a product, service, cause or institution that may be prejudicial to his honor or reputation.  Whenever requested to do so by the Company, and at the expense of the Company, the Executive shall execute any and all applications, assignments or other instruments which the Company shall reasonably deem necessary to apply for and obtain trademarks, patents or copyrights of the United States or any foreign country or otherwise protect the interests of the Company and its Affiliates therein with respect to the Developments.  These obligations shall continue beyond the end of the Executive’s employment with the Company with respect to Developments initiated, conceived or made by the Executive while employed by the Company, and shall be binding upon the Executive’s employers, assigns, executors, administrators and other legal representatives.  In connection with the Executive’s execution of this Agreement, the Executive has informed the Company in writing of any interest in any inventions or intellectual property rights related to the Company’s business that the Executive holds as of the date hereof.  If the Company is unable for any reason, after reasonable effort, to obtain the Executive’s signature on any document needed in connection with the actions described in this Section 4.6, the Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Executive’s agent and attorney in fact to act for and on the Executive’s behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of this Section 4.6 with the same legal force and effect as if executed by the Executive.
4.7.   Confidentiality of Agreement Other than with respect to information required to be disclosed by applicable law, the parties hereto agree not to disclose the terms of this Agreement to any Person; provided that the Executive may disclose this Agreement and/or any of its terms to the Executive’s immediate family, financial advisors and attorneys, so long as the Executive instructs every such Person to whom the Executive makes such disclosure not to disclose the terms of this Agreement further.  Any time after this Agreement is filed with the SEC or any other government agency by the Company and becomes a public record, this provision shall no longer apply .
4.8.   Remedies The Executive agrees that any breach of the terms of this Section 4 would result in irreparable injury and damage to the Company for which the Company would have no adequate remedy at law; the Executive therefore also agrees that in the event of said breach or any threat of breach, the Company shall be entitled to an immediate injunction and restraining order to prevent such breach, threatened breach and/or continued breach by the Executive and/or any and all Persons acting for and/or with the Executive, without having to prove damages, in addition to any other remedies to which the Company may be entitled at law or in equity.  The terms of this paragraph shall not prevent the Company from pursuing any other available remedies for any breach or threatened breach hereof, including, without limitation, the recovery of damages from the Executive.  The Executive and the Company further agree that the provisions of the covenants contained in this Section 4 are reasonable and necessary to protect the businesses of the Company and its Affiliates because of the Executive’s access to Confidential Information and the Executive’s material participation in the operation of such businesses .
Section 5.              Representations The Executive represents and warrants that (a) the Executive is not subject to any contract, arrangement, policy or understanding, or to any statute, governmental rule or regulation, that in any way limits the Executive’s ability to enter into and fully perform the Executive’s obligations under this Agreement and (b) the Executive is not otherwise unable to enter into and fully perform the Executive’s obligations under this Agreement.  In the event of a breach of any representation in this Section 5, the Company may terminate this Agreement and the Executive’s employment with the Company without any liability to the Executive and the Executive shall indemnify the Company for any liability it may incur as a result of any such breach .
Section 6.              Non-Disparagement From and after the Effective Date and following termination of the Executive’s employment with the Company (i) the Executive agrees not to make any statement that is intended to become public, or that should reasonably be expected to become public, and that criticizes, ridicules, disparages or is otherwise derogatory of the Company, any of its subsidiaries, Affiliates, employees, officers, directors or stockholders, and (ii) the Company agrees to instruct each director and executive officer of the Company not to make any statement that is intended to become public, or that should reasonably be expected to become public, and that criticizes, ridicules, disparages or is otherwise derogatory of the Executive .
Section 7.              Taxes; Clawbacks .
7.1. Withholding All amounts paid to the Executive under this Agreement during or following the Employment Period shall be subject to withholding and other employment taxes imposed by applicable law.  The Executive shall be solely responsible for the payment of all taxes imposed on the Executive relating to the payment or provision of any amounts or benefits hereunder .
7.2.   Section 280G .  (a)  In the event that shareholder approval is not obtained pursuant to Section 7.2(c) below, if (i) the aggregate of all amounts and benefits due to the Executive under this Agreement or under any other Company arrangement would, if received by the Executive in full and valued under Section 280G of the Code, constitute “parachute payments” as defined in and under Section 280G of the Code (collectively, “ 280G Benefits ”), and if (ii) such aggregate would, if reduced by all federal, state and local taxes applicable thereto, including the excise tax imposed pursuant to Section 4999 of the Code, be less than the amount the Executive would receive, after all taxes, if the Executive received aggregate 280G Benefits equal (as valued under Section 280G of the Code) to only three times the Executive’s “base amount” as defined in and under Section 280G of the Code, less $1.00, then (iii) such 280G Benefits as the Executive shall select shall (to the extent that the reduction of such 280G Benefits can achieve the intended result and such 280G Benefits are not subject to Section 409A of the Code) be reduced or eliminated to the extent necessary so that the aggregate 280G Benefits received by the Executive will not constitute parachute payments.  Notwithstanding the foregoing, if any 280G Benefits are subject to Section 409A of the Code or if the Executive fails to select an order under the preceding sentence, any such reduction shall occur in the following order: (i) by eliminating the acceleration of vesting of any stock options for which the exercise price exceeds the fair market value (and if there is more than one option award so outstanding, then the acceleration of the vesting of the most “under water” option shall be reduced first, and so-on); (ii) by reducing any cash payments not subject to Section 409A of the Code; (iii) by reducing any benefit continuation payments (and if there be more than one such payment, by reducing the payments in reverse order, with the payments made the earliest being reduced first); (iv), by reducing any cash payments that are subject to Section 409A of the Code (and if there be more than one such payment, by reducing the payments in reverse order, with the payments made the earliest being reduced first); (v) by reducing the payments of any restricted stock, restricted stock units, performance awards or similar equity-based awards that have been awarded to the Executive by the Company that are subject to performance-based vesting (and if there be more than one such award held by the Executive, by reducing the awards in the reverse order of the date of their award, with the most-recently awarded reduced first and the oldest award reduced last); (vi) by reducing the payments of any restricted stock, restricted stock units, performance awards or similar equity-based awards that have been awarded to the Executive by the Company that are subject to time-based vesting (and if there be more than one such award held by Executive, by reducing the awards in the reverse order of the date of their award, with the most-recently awarded reduced first and the oldest award reduced last); and (vii) by reducing the acceleration of vesting of any stock options that are not described in (i), above.
(b) It is possible that after the determinations and selections made pursuant to this Section 7.2, the Executive will receive 280G Benefits that are, in the aggregate, either more or less than the amount provided under this Section 7.2 (hereafter referred to as an “Excess Payment” or “Underpayment,” respectively).  If it is established, pursuant to a final determination of a court or an Internal Revenue Service proceeding that has been finally and conclusively resolved, that an Excess Payment has been made, then the Executive shall promptly pay an amount equal to the Excess Payment to the Company, together with interest on such amount at the applicable federal rate (as defined in and under Section 1274(d) of the Code) from the date of the Executive’s receipt of such Excess Payment until the date of such payment.  In the event that it is determined (i) by a court or (ii) by the Auditor upon request by a Party, that an Underpayment has occurred, the Company shall promptly pay an amount equal to the Underpayment to the Executive, together with interest on such amount at the applicable federal rate from the date such amount would have been paid to the Executive had the provisions of this Section 7.2 not been applied until the date of such payment .
(c) Notwithstanding the foregoing, if it appears that any amount or benefit that is to be paid to the Executive under this Agreement or any other plan, program, agreement, or arrangement of the Company or any of its Affiliates may constitute a “parachute payment” under Section 280G(b)(2) of the Code, the Company (if eligible to use such exemption) shall use its best reasonable efforts to obtain shareholder approval of such payments for purposes of Section 280G(b)(5) of the Code .
7.3.   Clawbacks If any law, rule or regulation applicable to the Company or its Affiliates (including any rule or requirement of any nationally recognized stock exchange on which the stock of the Company or its Affiliates has been listed), or any policy of the Company or its Affiliates reasonably designed to comply therewith, requires the forfeiture or recoupment of any amount paid or payable to the Executive hereunder (or under any other agreement between the Executive and the Company or its Affiliates or under any plan in which the Executive participates), the Executive hereby consents to such forfeiture or recoupment, in each case in the time and manner determined by the Company in its reasonable good faith discretion.  Furthermore, if the Executive engages in any act of embezzlement, fraud or dishonesty involving the Company or its Affiliates which results in a financial loss to the Company or its Affiliates, the Company shall be entitled to recoup an amount from the Executive determined by the Company in its reasonable discretion to be commensurate with such financial loss .
Section 8.              Miscellaneous .
8.1.   Indemnification and Insurance On the Effective Date, Parent and the Executive shall enter into the standard form of indemnification agreement that Parent offers to its Section 16 officers. The Executive shall be covered under any directors’ and officers’ insurance that the Company and Parent maintain for its directors and other officers in the same manner and on the same basis as the Company’s and Parent’s other directors and other senior officers .
8.2.   Amendments and Waivers This Agreement and any of the provisions hereof may be amended, waived (either generally or in a particular instance and either retroactively or prospectively), modified or supplemented, in whole or in part, only by written agreement signed by the parties hereto; provided that the observance of any provision of this Agreement may be waived in writing by the Party that will lose the benefit of such provision as a result of such waiver.  The waiver by either Party of a breach of any provision of this Agreement shall not operate or be construed as a further or continuing waiver of such breach or as a waiver of any other or subsequent breach, except as otherwise explicitly provided for in such waiver.  Except as otherwise expressly provided herein, no failure on the part of either Party to exercise, and no delay in exercising, any right, power or remedy hereunder, or otherwise available in respect hereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such Party preclude any other or further exercise thereof or the exercise of any other right, power or remedy.
8.3.   Assignment; No Third-Party Beneficiaries This Agreement, and the Executive’s rights and obligations hereunder, may not be assigned by the Executive, and any purported assignment by the Executive in violation hereof shall be null and void.  Nothing in this Agreement shall confer upon any Person not a party to this Agreement, or the legal representatives of such Person, any rights or remedies of any nature or kind whatsoever under or by reason of this Agreement, except the personal representative of the deceased Executive may enforce the provisions hereof applicable in the event of the death of the Executive.  The Company is authorized to assign this Agreement and its rights and obligations hereunder without the consent of the Executive as part of the transfer of all or substantially all of its properties or assets to any other Person or entity .
8.4.   Notices Unless otherwise provided herein, all notices, requests, demands, claims and other communications provided for under the terms of this Agreement shall be in writing.  Any notice, request, demand, claim or other communication hereunder shall be sent by (i) personal delivery (including receipted courier service) or overnight delivery service, with confirmation of receipt, (ii) e-mail, (iii) facsimile, with confirmation of receipt, to the number indicated, (iv) reputable commercial overnight delivery service courier, with confirmation of receipt or (v) registered or certified mail, return receipt requested, postage prepaid and addressed to the intended recipient as set forth below :
If to the Company or Parent:

Emerald Expositions, LLC
31910 Del Obispo St., Suite 200
San Juan Capistrano, CA  92675
Attention:  Chairman of the Board and General Counsel

with a copy to:

Fried, Frank, Harris, Shriver & Jacobson LLP
One New York Plaza
New York, NY  10004
Attention:  Jeffrey Ross, Esq.
Facsimile:  212-859-4000

If to the Executive:  At the Executive’s principal office at the Company (during the Employment Period), and at all times to the Executive’s principal residence as reflected in the records of the Company. If by e-mail, to the Executive’s Company-supplied e-mail address.

with a copy to:

Briggs and Morgan, P.A.
2200 IDS Center
80 South 8th Street
Minneapolis, MN 55402
Attention: Steve Kozachok

All such notices, requests, consents and other communications shall be deemed to have been given when received (or the following business day in the case of emails or facsimiles delivered after normal business hours at the location of the recipient).  Either Party may change its facsimile number or its address to which notices, requests, demands, claims and other communications hereunder are to be delivered by giving the other parties hereto notice in the manner then set forth.

8.5.   Governing Law This Agreement shall be construed and enforced in accordance with, and the rights and obligations of the parties hereto shall be governed by, the laws of the State of New York without giving effect to the conflicts of law principles thereof.
8.6.   Jurisdiction; Waiver of Jury Trial The Executive agrees that jurisdiction and venue for any action arising from or relating to this Agreement or the relationship among the parties hereto, including but not limited to matters concerning validity, construction, performance, or enforcement, shall be exclusively in the federal and state courts of the State of New York located in New York County (collectively, the “ Selected Courts ”) (provided, that a final judgment in any such action shall be conclusive and enforced in other jurisdictions) and further agree that service of process may be made in any matter permitted by law.  The Executive irrevocably waives and agrees not to assert (i) any objection which he may ever have to the laying of venue of any action or proceeding arising out of this Agreement or the transactions contemplated hereby in the Selected Courts, and (ii) any claim that any such action brought in any such court has been brought in an inconvenient forum.  This Section 8.6 is intended to fix the location of potential litigation among the parties hereto and does not create any causes of action or waive any defenses or immunities to suit.  EACH PARTY WAIVES ANY RIGHT TO A TRIAL BY JURY, TO THE EXTENT LAWFUL, AND AGREES THAT ANY OF THEM MAY FILE A COPY OF THIS PARAGRAPH WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE ITS RIGHT TO TRIAL BY JURY IN ANY LITIGATION WHATSOEVER BETWEEN THEM RELATING TO THIS AGREEMENT OR THE CONTEMPLATED TRANSACTIONS.
8.7.   Severability Whenever possible, each provision or portion of any provision of this Agreement, including those contained in Section 4 hereof, will be interpreted in such manner as to be effective and valid under applicable law but the invalidity or unenforceability of any provision or portion of any provision of this Agreement in any jurisdiction shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of this Agreement, including that provision or portion of any provision, in any other jurisdiction.  In addition, should a court or arbitrator determine that any provision or portion of any provision of this Agreement, including those contained in Section 4 hereof, is not reasonable or valid, either in period of time, geographical area, or otherwise, the Parties agree that such provision should be interpreted and enforced to the maximum extent which such court or arbitrator deems reasonable or valid .
8.8.   Entire Agreement From and after the Effective Date, this Agreement constitutes the entire agreement among the parties hereto, and supersedes all prior representations, agreements and understandings (including any prior course of dealings), both written and oral, among the parties hereto with respect to the subject matter hereof .
8.9.   Counterparts This Agreement may be executed by .pdf or facsimile signatures in any number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one and the same instrument .
8.10.   Binding Effect This Agreement shall inure to the benefit of, and be binding on, the successors and assigns of each of the parties hereto, including, without limitation, the Executive’s heirs and the personal representatives of the Executive’s estate and any successor to all or substantially all of the business and/or assets of the Company or Parent .
8.11.   General Interpretive Principles The name assigned to this Agreement and headings of the sections, paragraphs, subparagraphs, clauses and subclauses of this Agreement are for convenience of reference only and shall not in any way affect the meaning or interpretation of any of the provisions hereof.  Words of inclusion shall not be construed as terms of limitation herein, so that references to “include,” “includes” and “including” shall not be limiting and shall be regarded as references to non-exclusive and non-characterizing illustrations.  Any reference to a Section of the Code shall be deemed to include any successor to such Section .
8.12.   Affiliates .   For purposes of this Agreement, the term “ Affiliates ” means any person or entity Controlling, Controlled by, or Under Common Control with the Company.  The term “ Control ,” including the correlative terms “ Controlling ,” “ Controlled By ,” and “ Under Common Control with ” means possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities of any company or other ownership interest, by contract or otherwise) of a person or entity.
[signature page follows]

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.
 
EMERALD EXPOSITIONS, LLC
 
     
     
 
By:
/s/ David Gosling
 
 
Name:
David Gosling
 
 
Title:
SVP, General Counsel and Secretary
 



 
EMERALD EXPOSITIONS EVENTS, INC.
 
  (solely for purposes of Sections 2.3 and 8.1 of this Agreement)  
     
     
 
By:
/s/ David Gosling
 
 
Name:
David Gosling
 
 
Title:
SVP, General Counsel and Secretary
 



  EXECUTIVE  
     
 
/s/ Brian Field
 
 
Brian Field
 
 

Exhibit A
Form of Performance Based Share Award Agreement

Exhibit B
You should consult with an attorney before signing this release of claims.
Release
1. In consideration of the payments and benefits to be made under the Employment Agreement, dated as of May 22, 2019 (the “ Employment Agreement ”), by and between Brian Field (the “ Executive ”) and Emerald Expositions, LLC, (the “ Company ”) (each of the Executive and the Company, a “ Party ” and collectively, the “ Parties ”), and solely for the purpose of Section 2.3 of the Employment Agreement, Emerald Expositions Events, Inc., (“ Parent ”), the sufficiency of which the Executive acknowledges, the Executive, with the intention of binding the Executive and the Executive’s heirs, executors, administrators and assigns, does hereby release, remise, acquit and forever discharge the Company and each of its subsidiaries and Affiliates (the “ Company Affiliated Group ”), their present and former officers, directors, executives, shareholders, insurers, agents, attorneys, employees and employee benefit plans (and the fiduciaries thereof), and the successors, predecessors and assigns of each of the foregoing (collectively, the “ Company Released Parties ”), of and from any and all claims, actions, causes of action, complaints, charges, demands, rights, damages, debts, sums of money, accounts, financial obligations, suits, expenses, attorneys’ fees and liabilities of whatever kind or nature in law, equity or otherwise, whether accrued, absolute, contingent, unliquidated or otherwise and whether now known or unknown, suspected or unsuspected, which the Executive, individually or as a member of a class, now has, owns or holds, or has at any time heretofore had, owned or held, arising on or prior to the date hereof, against any Company Released Party that arises out of, or relates to, the Employment Agreement, the Executive’s employment with the Company or any of its subsidiaries and Affiliates, or any termination of such employment, including claims (i) for severance, unpaid wages, salary or incentive payments, (ii) for breach of contract, wrongful discharge, impairment of economic opportunity, defamation, intentional infliction of emotional harm or other tort, (iii) for any violation of applicable state and local labor and employment laws (including, without limitation, all laws concerning unlawful and unfair labor and employment practices)   and (iv) for employment discrimination under any applicable federal, state or local statute, provision, order or regulation, and including, without limitation, any claim under Title VII of the Civil Rights Act of 1964 (“ Title VII ”), the Civil Rights Act of 1988, the Fair Labor Standards Act, the Americans with Disabilities Act (“ ADA ”), the Employee Retirement Income Security Act of 1974, as amended (“ ERISA ”), the Age Discrimination in Employment Act (“ ADEA ”), the New York Labor Code (specifically including the New York Retaliatory Action by Employers Law, the New York State Worker Adjustment and Retraining Notification Act, the New York Nondiscrimination for Legal Actions Law and Article 6 of the New York Labor Law (which regulates the payment of wages and prohibits employers from discriminating in wages based on sex)), Section 125 of the New York Workers’ Compensation Law, Article 4 of the New York Civil Rights Law, and any similar or analogous state statute, excepting only:
A.
rights of the Executive arising under, or preserved by, this Release or Section 3 of the Employment Agreement;
B.
the right of the Executive to receive COBRA continuation coverage in accordance with applicable law ;
C.
claims for benefits under any health, disability, retirement, life insurance or other, similar employee benefit plan (within the meaning of Section 3(3) of ERISA) of the Company Affiliated Group ;
D.
rights to indemnification the Executive has or may have under the by-laws or certificate of incorporation of any member of the Company Affiliated Group or as an insured under any director’s and officer’s liability insurance policy now or previously in force; and
E.
rights granted to the Executive during the Executive’s employment related to the purchase and/or grant of equity of Emerald Expositions Events, Inc.
2.   The Executive acknowledges and agrees that this Release is not to be construed in any way as an admission of any liability whatsoever by any Company Released Party, any such liability being expressly denied.
3.   This Release applies to any relief no matter how called, including, without limitation, wages, back pay, front pay, compensatory damages, liquidated damages, punitive damages, damages for pain or suffering, costs, and attorneys’ fees and expenses.
4.   The Executive specifically acknowledges that the Executive’s acceptance of the terms of this Release is, among other things, a specific waiver of the Executive’s rights, claims and causes of action under Title VII, ADEA, ADA and any state or local law or regulation in respect of discrimination of any kind; provided, however, that nothing herein shall be deemed, nor does anything contained herein purport, to be a waiver of any right or claim or cause of action which by law the Executive is not permitted to waive.
5.   The Executive acknowledges that the Executive has been given a period of twenty-one (21) days to consider whether to execute this Release.  If the Executive accepts the terms hereof and executes this Release, the Executive may thereafter, for a period of seven (7) days following (and not including) the date of execution, revoke this Release.  Any revocation within this period must be submitted, in writing, to Eileen Deady, VP, HR, Emerald Expositions, LLC, 100 Broadway, 14th Floor, New York, NY 10005, and must state: “I hereby revoke my acceptance of the Release of Claims.”  The revocation must be either: (a) personally delivered to Eileen Deady within 7 calendar days after the day Executive signs the Release; (b) mailed to Eileen Deady at the address specified above by First Class United States mail and postmarked within 7 calendar days after the day Executive signs the Release; or (c) delivered to Eileen Deady at the address specified above through a reputable overnight delivery service with documented evidence that it was sent within 7 calendar days after the day Executive signed the Release.  If no such revocation occurs, this Release shall become irrevocable in its entirety, and binding and enforceable against the Executive, on the day next following the day on which the foregoing seven-day period has elapsed.  If such a revocation occurs, the Executive shall irrevocably forfeit any right to payment of the Severance Amount and the Pro-Rata Bonus and  provision of the Medical Benefit Continuation (as each is defined in the Employment Agreement), but the remainder of the Employment Agreement shall continue in full force.
6.   The Executive acknowledges and agrees that the Executive has not, with respect to any transaction or state of facts existing prior to the date hereof, filed or caused to be filed, and is not presently a party to, any complaints, charges or lawsuits against any Company Released Party with any governmental agency, court or tribunal.  The Executive agrees to immediately withdraw or dismiss any complaints, charges or lawsuits that she has filed or caused to be filed, or to which she is a party, against any Company Released Party.  Solely with respect to the claims waived in this Release, the Executive (a) agrees not to file or maintain any complaint, charge or lawsuit against any Company Released Party and (b) agrees not to (i) participate in, or encourage the pursuit of, any claims, or (ii) accept payment from any litigation or threatened litigation against any Company Released Party, unless compelled to testify pursuant to subpoena or order of a court of competent jurisdiction .
7.   THE EXECUTIVE ACKNOWLEDGES THAT THE EXECUTIVE HAS BEEN ADVISED TO SEEK, AND HAS HAD THE OPPORTUNITY TO SEEK, THE ADVICE AND ASSISTANCE OF AN ATTORNEY WITH REGARD TO THIS RELEASE, AND HAS BEEN GIVEN A SUFFICIENT PERIOD WITHIN WHICH TO CONSIDER THIS RELEASE.
8.   The Executive acknowledges that this Release relates only to claims that exist as of the date of this Release.
9.   The Executive acknowledges that the severance payments and benefits the Executive is receiving in connection with this Release and the Executive’s obligations under this Release are in addition to anything of value to which the Executive is entitled from the Company.
10.   Each provision hereof is severable from this Release, and if one or more provisions hereof are declared invalid, the remaining provisions shall nevertheless remain in full force and effect.  If any provision of this Release is so broad, in scope, or duration or otherwise, as to be unenforceable, such provision shall be interpreted to be only so broad as is enforceable.
11.   This Release constitutes the complete agreement of the Parties in respect of the subject matter hereof and shall supersede all prior agreements between the Parties in respect of the subject matter hereof except to the extent set forth herein.   For the avoidance of doubt, however, nothing in this Release shall constitute a waiver of any Company Released Party’s right to enforce any obligations of the Executive under the Employment Agreement that survive the Employment Agreement’s termination, including without limitation, any non-competition covenant, non-solicitation covenant or any other restrictive covenants contained therein.
12.   The failure to enforce at any time any of the provisions of this Release or to require at any time performance by another party of any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to affect the validity of this Release, or any part hereof, or the right of any party thereafter to enforce each and every such provision in accordance with the terms of this Release.
13.   This Release may be executed in counterparts, both of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.  Signatures delivered by facsimile, email or pdf shall be deemed effective for all purposes.
14.   This Release shall be binding upon any and all successors and assigns of the Executive and the Company.
15.   Except for issues or matters as to which federal law is applicable, this Release shall be governed by and construed and enforced in accordance with the laws of the State of New York without giving effect to the conflicts of law principles thereof.
16.   Employee further affirms that he has timely been paid or has received all compensation, wages, bonuses, commissions and benefits   to which he may be entitled and that no other leave (paid or unpaid), compensation, wages, bonuses, commissions or benefits are due to him except as follows:
 

 
 
 
 
     

[signature page follows]

IN WITNESS WHEREOF, this Release has been signed by or on behalf of each of the Parties, all as of ____________________.


 
EMERALD EXPOSITIONS, LLC
 
     
     
 
By:

 
 
Name:

 
 
Title:

 



  EXECUTIVE  
     
 

 
 
Brian Field
 
 




Exhibit 10.2



EMERALD EXPOSITIONS EVENTS, INC.
2017 OMNIBUS EQUITY PLAN

RESTRICTED STOCK UNIT
AWARD AGREEMENT

Pursuant to Section 8 of the 2017 Omnibus Equity Plan (the “ Plan ”) of Emerald Expositions Events, Inc. (the “ Company ”), on [June 3], 2019 (the “ Grant Date ”) the Company authorized a grant to Brian Field (the “ Recipient ”) of an award of restricted stock units with respect to the Company’s Common Stock (“ Common Stock ”), subject to the terms and conditions of this agreement between the Company and the Recipient (this “ Agreement ”). By accepting this award, the Recipient agrees to all of the terms and conditions of this Agreement. The Company and the Recipient understand and agree that any capitalized terms used herein, if not otherwise defined, shall have the same meanings as in the Plan (the Recipient being referred to in the Plan as a Participant).
1.   Award and Terms of Restricted Stock Units . The Company awards to the Recipient under the Plan [_____] 1 restricted stock units (the “ Award ”), subject to the restrictions, conditions and limitations set forth in this Agreement and in the Plan, which is incorporated herein by reference. The Recipient acknowledges receipt of a copy of the Plan and acknowledges that the definitive records pertaining to the grant of this Award, and exercises of rights hereunder, shall be retained by the Company.
(a)   Rights under Restricted Stock Units . A restricted stock unit (“ RSU ”) obligates the Company, upon vesting and in accordance with this Agreement, to issue to the Recipient one share of Common Stock for each RSU .
(b)   Vesting Dates . The RSUs awarded under this Agreement shall initially be 100% unvested and subject to forfeiture. Subject to Sections 1(c) and 2 of this Agreement, 33.3% of the RSUs shall vest and be released from the forfeiture provisions on each of the first three (3) anniversaries of the Grant Date (each a “ Vesting Date ”), provided the Recipient has not Terminated prior to the applicable Vesting Date. If at any time prior to the third (3 rd ) anniversary of the Grant Date, the Recipient’s employment is terminated (i) by the Company or a Subsidiary without Cause, or (ii) by the Recipient for Good Reason, 100% of the then remaining unvested RSUs will become immediately vested.  For purposes of this Agreement, “Cause” and “Good Reason” shall have the meanings given to such terms in the Employment Agreement between the Recipient and Emerald Expositions, LLC dated as of May 22, 2019 (the “ Employment Agreement ”) .
(c)    Forfeiture of RSUs on Termination of Employment . Subject to the second sentence of Section 1(b), if the Recipient Terminates for any reason, all outstanding and unvested RSUs awarded pursuant to this Agreement shall be immediately and automatically forfeited to the Company for no consideration. Upon a termination for Cause, all outstanding vested and unvested RSUs awarded pursuant to this Agreement shall be immediately and automatically forfeited for no consideration .
(d)   Restrictions on Transfer . The Recipient may not sell, transfer, assign, pledge or otherwise encumber or dispose of the RSUs other than to the extent permitted by Section 11.2 of the Plan .
(e)   No Shareholder Rights . The Recipient shall have no rights as a shareholder with respect to the RSUs or the Common Stock underlying the RSUs until the underlying Common Stock is issued to the Recipient .
(f)   Reserved .
(g)   Delivery Date for the Shares Underlying the Vested RSU . As soon as practicable, but in no event later than 15 days following a date on which any RSUs vest, the Company will issue to the Recipient the Common Stock underlying the then-vested RSUs, subject to Section 1(h). The shares of Common Stock will be issued in the Recipient’s name or, in the event of the Recipient’s death after the date of vesting but before the date of delivery, in the name of either (i) the beneficiary designated by the Recipient on a form supplied by the Company or (ii) if the Recipient has not designated a beneficiary, the person or persons establishing rights of ownership by will or under the laws of descent and distribution .



1 NTD: A number of shares with an aggregate value equal to $245,000 based on the stock price on the Grant Date, which is expected to be June 3, 2019. Note that the number of shares to be delivered on settlement of the RSUs will be reduced by the withholding taxes on the date of settlement pursuant to Section 1(h) hereof .


(h)   Taxes and Tax Withholding . The Recipient acknowledges and agrees that no election under Section 83(b) of the Internal Revenue Code of 1986, as amended, can or will be made with respect to the RSUs. The Recipient acknowledges that on each date that shares underlying the RSUs are issued to the Recipient (the “ Payment Date ”), the Fair Market Value on that date of the shares so issued will be treated as ordinary compensation income for federal and state income and FICA tax purposes, and that the Company will be required to withhold taxes on these income amounts. To satisfy the withholding amount (determined in accordance with applicable law), the Company will withhold from the shares otherwise issuable upon a Payment Date the number of shares having a Fair Market Value equal to the withholding amount (up to the statutory maximum amount) or the Committee may in its sole discretion authorize another method to be utilized under procedures established by the Company .
(i)   Not a Contract of Employment . Nothing in the Plan or this Agreement shall confer upon Recipient any right to be continued in the employment of the Company or any Affiliate, or to interfere in any way with the right of the Company or any parent or subsidiary by whom Recipient is employed to Terminate the Recipient’s employment at any time or for any reason, with or without cause, or to decrease Recipient’s compensation or benefits .
2.   Prohibited Conduct; Restatements .
(a)   Consequences of Prohibited Conduct . In consideration of and as a condition to the grant of the Award, the Recipient agrees to not engage in Prohibited Conduct (as defined in Section 2(b)). If the Company determines that the Recipient has engaged in any Prohibited Conduct, then:
    (i)   The Recipient shall immediately forfeit all outstanding RSUs awarded pursuant to this Agreement and shall have no right to receive the underlying shares; and
   (ii) If the Payment Date for any RSUs has occurred, and the Company determines on or before the first anniversary of a Vesting Date for such RSUs that the Recipient has engaged in Prohibited Conduct, the Recipient shall repay and transfer to the Company the number of shares of Common Stock issued to the Recipient under this Agreement on that Payment Date (the “ Forfeited Shares ”) and a cash payment equal to the applicable withholding taxes. If any Forfeited Shares have been sold by the Recipient prior to the Company’s demand for repayment, the Recipient shall repay to the Company 100% of the proceeds of such sale or sales and a cash payment equal to the applicable employer withholding taxes paid on the Payment Date. The Company may, in its sole discretion, reduce the amount to be repaid by the Recipient to take into account the tax consequences of such repayment for the Recipient.
(b)   Prohibited Conduct . For purposes of this Agreement, Prohibited Conduct means that the Recipient has violated any restrictive covenant contained in the Employment Agreement .
(c)   Restatement of Financial Statements . In addition to the other provisions in this Section 2, this Agreement, the RSUs and any shares issued under the RSUs shall be subject to any policies of the Company in effect on the Grant Date or adopted by the Company at any time thereafter that provide for forfeiture of the RSUs and recoupment of any shares issued under the RSUs or of any gain received by the Recipient in connection with the sale of shares received in settlement of RSUs in the event of any restatement of the Company’s financial statements .
(d)   Determinations . The Committee shall, in its sole discretion, make all determinations regarding this Section 2, including whether any Prohibited Conduct has occurred, and the determinations by the Committee shall be final and binding on all parties .
3.   Securities Laws . The obligation of the Company, as applicable, to issue and deliver the RSUs and any shares of Common Stock hereunder shall be subject to all applicable laws, rules and regulations, and such approvals by governmental agencies as may be required.  The Recipient hereby agrees not to offer, sell or otherwise attempt to dispose of any shares of Common Stock issued to the Recipient pursuant to this Agreement in any way which would: (x) require the Company to file any registration statement with the Securities and Exchange Commission (or any similar filing under state law or the laws of any other county) or to amend or supplement any such filing or (y) violate or cause the Company to violate the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, or any other Federal, state or local law, or the laws of any other country .
4.   Notices . All notices, consents and other communications required or permitted to be given under or by reason of this Agreement shall be in writing, shall be delivered personally or by e-mail or as described below or by reputable overnight courier, and shall be deemed given on the date on which such delivery is made. If delivered by e-mail or fax, such notices or communications shall be confirmed by a registered or certified letter (return receipt requested), postage prepaid. Any such delivery shall be addressed to the intended recipient at the following addresses (or at such other address for a party as shall be specified by such party by like notice to the other party) :
 
To the Company:
Emerald Expositions Events, Inc.
31910 Del Obispo, Suite 200
San Juan Capistrano, CA 92675
Attention: David Gosling
Email: David.Gosling@emeraldexpo.com
     
 
To the Recipient:
At the most recent address or email contained in the Company’s records.

5.   Governing Law; Submission to Jurisdiction; Waiver of Jury Trial This Agreement shall in all respects be governed by, and construed in accordance with, the laws (excluding conflict of laws rules and principles) of the State of New York applicable to agreements made and to be performed entirely within such State, including all matters of construction, validity and performance.  Any litigation against any party to this Agreement arising out of or in any way relating to this Agreement shall be brought in any federal or state court located in the State of New York in New York County and each of the parties hereby submits to the exclusive jurisdiction of such courts for the purpose of any such litigation; provided, that a final judgment in any such litigation shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.  Each party irrevocably and unconditionally agrees not to assert (i) any objection which it may ever have to the laying of venue of any such litigation in any federal or state court located in the State of New York in New York County, (ii) any claim that any such litigation brought in any such court has been brought in an inconvenient forum and (iii) any claim that such court does not have jurisdiction with respect to such litigation.  To the extent that service of process by mail is permitted by applicable law, each party irrevocably consents to the service of process in any such litigation in such courts by the mailing of such process by registered or certified mail, postage prepaid, at its address for notices provided for herein.  Each party hereto irrevocably and unconditionally waives any right to a trial by jury and agrees that either of them may file a copy of this paragraph with any court as written evidence of the knowing, voluntary and bargained-for agreement among the parties irrevocably to waive its right to trial by jury in any litigation .
6.   Specific Performance Each of the parties agrees that any breach of the terms of this Agreement will result in irreparable injury and damage to the other party, for which there is no adequate remedy at law.  Each of the parties therefore agrees that in the event of a breach or any threat of breach, the other party shall be entitled to an immediate injunction and restraining order to prevent such breach, threatened breach or continued breach, and/or compelling specific performance of the Agreement, without having to prove the inadequacy of money damages as a remedy or balancing the equities between the parties.  Such remedies shall be in addition to any other remedies (including monetary damages) to which the other party may be entitled at law or in equity.  Each party hereby waives any requirement for the securing or posting of any bond in connection with any such equitable remedy .
7.   Binding Effect . This Agreement shall (subject to the provisions of Section 1(d) hereof) be binding upon the heirs, executors, administrators, successors and assigns of the parties hereto .
8.   Severability . Each provision of this Agreement will be treated as a separate and independent clause and unenforceability of any one clause will in no way impact the enforceability of any other clause. Should any of the provisions of this Agreement be found to be unreasonable or invalid by a court of competent jurisdiction, such provision will be enforceable to the maximum extent enforceable by the law of that jurisdiction .
9.   Amendments and Waivers . Subject to applicable law, this Agreement and any of the provisions hereof may be amended, modified, supplemented or cancelled, in whole or in part, prospectively or retroactively, in each case by the Committee; provided that no such action shall adversely affect the Recipient’s material rights under this Agreement without the Recipient’s consent. The waiver by a party hereto of a breach by another party hereto of any provision of this Agreement shall not operate or be construed as a further or continuing waiver of such breach by such other party or as a waiver of any other or subsequent breach by such other party, except as otherwise explicitly provided for in the writing evidencing such waiver. Except as otherwise expressly provided herein, no failure on the part of any party to exercise, and no delay in exercising, any right, power or remedy hereunder, or otherwise available in respect hereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such party preclude any other or further exercise thereof or the exercise of any other right, power or remedy .
10.   Counterparts . This Agreement may be executed by .pdf or facsimile signatures and in any number of counterparts with the same effect as if all signatory parties had signed the same document. All counterparts shall be construed together and shall constitute one and the same instrument .

[signature page follows]


IN WITNESS WHEREOF, the Company and the Recipient have caused this Agreement to be executed on their behalf, by their duly authorized representatives, all on the day and year first above written .


 
EMERALD EXPOSITIONS EVENTS, INC.
 
       
  By:

 
 
  David Gosling
 
    SVP, General Counsel and Secretary
 



 
RECIPIENT:
 
     
 
 
 
Brian Field
 

[Signature Page to RSU Award Agreement]

Exhibit 10.3




EMERALD EXPOSITIONS EVENTS, INC.
2017 OMNIBUS EQUITY PLAN

STOCK OPTION AGREEMENT

THIS AGREEMENT (the “ Agreement ”), effective as of [June 3, 2019] (the “ Date of Grant ”), is between Emerald Expositions Events, Inc., a Delaware corporation (together with its successors, the “ Company ”), and the individual whose name is set forth on the signature page hereto (the “ Optionee ”).
Section 1.             Grant of Option .  The Company hereby grants to the Optionee the right and option (the “ Option ”) to purchase all or any part of an aggregate of such number of Shares (“ Option Shares ”) as is set forth on the signature page hereto (subject to adjustment as provided in Section 12 of the Emerald Expositions Events, Inc. 2017 Omnibus Equity Plan (as may be amended from time to time, the “ Plan ”)) on the terms and conditions set forth in this Agreement and in the Plan, a copy of which is being delivered to the Optionee concurrently herewith and is made a part hereof as if fully set forth herein.  The grant shall be effective upon the execution of this Agreement by both parties hereto.  Except as otherwise defined herein, capitalized terms used in this Agreement shall have the same definitions as set forth in the Plan.  The Option is not intended to qualify as an Incentive Stock Option within the meaning of Section 422 of the Code.
Section 2.             Purchase Price .  The price (the “ Option Price ”) at which the Optionee shall be entitled to purchase Option Shares upon the exercise of the Option shall be the price per Share set forth on the signature page hereto (subject to adjustment as provided in Section 12 of the Plan).
Section 3.             Term of Option .  The Option shall be exercisable to the extent and in the manner provided herein until the close of business on the day preceding the 10 th anniversary of the Date of Grant (the “ Term ”); provided , however , that the Option may be earlier terminated as provided in Section 6, 7 or 8 hereof.
Section 4.             Exercisability of Option .
4.1.             Vesting .  Subject to the provisions of this Agreement and the Plan, the Option shall vest and become exercisable in accordance with the following schedule:
(a)   Prior to the first anniversary of the Date of Grant, the Option may not be exercised;
(b)   On or after the first anniversary of the Date of Grant but before the second anniversary of the Date of Grant, the Option may be exercised to acquire up to 33.3% of the aggregate number of Option Shares;
(c)   On or after the second anniversary of the Date of Grant but before the third anniversary of the Date of Grant, the Option may be exercised to acquire up to 66.6% of the aggregate number of Option Shares, less any Option Shares previously acquired pursuant to the Option;
(d)   On or after the third anniversary of the Date of Grant, the Option may be exercised to acquire up to 100% of the aggregate number of Option Shares, less any Option Shares previously acquired pursuant to the Option.
(e)               Notwithstanding the foregoing, if a Change in Control occurs and the Optionee is T erminated by the Company or a Subsidiary within 3 months before or 18 months after the Change in Control (other than a Termination of the Optionee for Cause), the Option shall become 100% vested and exercisable. For purposes of this Agreement, “ Cause ” shall have the meaning given to such term in the Employment Agreement between the Recipient and Emerald Expositions, LLC dated as of May 22, 2019 (the “ Employment Agreement ”).
The portion of the Option which becomes vested and exercisable as described in this Section 4.1 is hereinafter referred to as the “ Vested Portion .”
Section 5.             Manner of Exercise and Payment .
5.1.             Notice of Exercise .  The Option shall be exercised when written notice of such exercise in substantially the form attached hereto as Exhibit A or such other form as the Committee may require from time to time (the “ Exercise Notice ”), signed by the person entitled to exercise the Option, has been delivered to the Company in accordance with the provisions of Section 9.6 hereof.  The Exercise Notice shall state that the Optionee is electing to exercise the Option, shall set forth the number of Option Shares in respect of which the Option is being exercised and shall be signed by the Optionee or, where applicable, by the Optionee’s legal representative.
5.2.             Deliveries .  The Exercise Notice described in Section 5.1 shall be accompanied by payment of the full Option Price for the Option Shares in respect of which the Option is being exercised, together with any withholding taxes that may be due as a result of the exercise of the Option, such payment to be made by delivery to the Company of (a) a certified or bank check payable to the order of the Company, or (b) cash by wire transfer or other immediately available funds to an account designated by the Company.  Alternatively, the Committee may in its sole discretion permit the Optionee to (x) utilize a broker-assisted “cashless exercise” program, (y) have withheld from the number of Option Shares otherwise issuable following the exercise of the Option the number of Option Shares having a Fair Market Value equal to the exercise price and/or withholding amount due (up to the maximum statutory rate) in accordance with applicable law or (z) allow another method or combination of methods under procedures established by the Company.
5.3.   Issuance of Shares .  Subject to Section 18.2 of the Plan, upon receipt of the Exercise Notice and full payment for the Option Shares in respect of which the Option is being exercised, the Company shall take such action as may be necessary under applicable law to cause the issuance to the Optionee of the number of Option Shares as to which the Option was exercised and the Optionee shall cooperate to the fullest extent requested by the Company (including by executing such documents and providing such information) as may be necessary to effect the issuance of such Option Shares in compliance with all applicable law.  If the Optionee fails to make any of the deliveries required by Section 5.2 of this Agreement, the Optionee’s exercise shall not be given effect and the Shares shall not be issued to the Optionee.
5.4.   Shareholder Rights .  The Optionee shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to, any Option Shares until: (a) the Option shall have been exercised in accordance with the terms of this Agreement and the Optionee shall have paid the full Option Price for the number of Option Shares in respect of which the Option was exercised and any withholding taxes due, (b) the Company shall have issued the Option Shares to the Optionee and (c) the Optionee’s name shall have been entered as a holder of record on the books of the Company.  Upon the occurrence of all of the foregoing events, the Optionee shall have full ownership rights with respect to such Option Shares.
Section 6.             Termination .
6.1.             Termination .  If the Optionee Terminates, (a) subject to Section 4.1(f), the Option, other than the Vested Portion of the Option, shall terminate and be of no further force and effect as of and following the close of business on the date of such Termination, and (b) the Vested Portion of the Option shall be exercisable by the Optionee during the Post-Termination Exercise Period (as defined below), but in no event after the expiration of the Term.  Any portion of the Vested Portion of the Option that, following the Optionee’s Termination, is not exercised prior to the expiration of the Post-Termination Exercise Period shall terminate at the end of the Post-Termination Exercise Period.  Notwithstanding anything in this Agreement or the Plan to the contrary, the Option, whether or not exercisable, shall immediately terminate (a) upon a Termination of the Optionee by the Company or a Subsidiary for Cause, (b) in the event that the Optionee violates any provision of Section 7 hereof or (c) in the event that the Optionee violates any provision of any Restrictive Agreement (as hereinafter defined).
6.2.             Post-Termination Exercise Period ” shall mean the period commencing on the Optionee’s Termination and ending at the close of business on the 90 th day after the date of the Optionee’s Termination.  Notwithstanding anything to the contrary herein, in the event of the Optionee’s death or Disability, the Post-Termination Exercise Period shall mean the period commencing on the Optionee’s death or Disability and ending at the close of business on the 180 th day after the date of the Optionee’s death or Disability.
Section 7.             Prohibited Activities .  In consideration of and as a condition to the grant of the Option, the Optionee agrees to the covenants set forth in this Section 7.

7.1.             No Sale or Transfer .  The Optionee shall not sell, transfer, assign, grant a participation in, gift, hypothecate, encumber, mortgage, create any lien, pledge, exchange or otherwise dispose of the Option or any portion thereof other than to the extent permitted by Section 11.2 of the Plan.
7.2.             Right to Terminate Option .  The Optionee understands and agrees that the Company has granted this Option to the Optionee to reward the Optionee for the Optionee’s future efforts and loyalty to the Company and its affiliates by giving the Optionee the opportunity to participate in the potential future appreciation of the Company.  Accordingly, if the Optionee (a) engages in any activity prohibited by Section 7 of this Agreement, (b) breaches or violates any obligations under any Restrictive Agreement to which the Optionee is a party or (c) is convicted of a felony against the Company or any of its affiliates, then, in addition to any other rights and remedies available to the Company, the Company shall be entitled, at its option, exercisable by written notice, to terminate the Option (including the Vested Portion of the Option), or any unexercised portion thereof, which shall be of no further force and effect.  For the sake of clarity, the foregoing rights of the Company in this Section 7.2 apply only to the outstanding portion of the Option, and shall not apply to any Shares acquired upon exercise of any portion of the Option.
7.3.             Remedies .  The Optionee specifically acknowledges and agrees that the Company’s remedies under this Section 7 shall not prevent the Company or any Subsidiary from seeking injunctive or other equitable relief in connection with the Optionee’s breach of any Restrictive Agreement.  In the event that the provisions of this Section 7 should ever be deemed to exceed the limitation provided by applicable law, then the Optionee and the Company agree that such provisions shall be reformed to set forth the maximum limitations permitted.
7.4.             Restatement of Financial Statements .  In addition to the other provisions in this Section 7, this Agreement, the Option and any Shares issued upon exercise of any portion of the Option shall be subject to any policies of the Company in effect on the Date of Grant or adopted by the Company at any time thereafter that provide for forfeiture of the Option and recoupment of any Shares issued upon exercise of any portion of the Option or of any gain received by the Optionee in connection with the sale of Shares received upon exercise of the Option in the event of any restatement of the Company’s financial statements.
7.5.             Survival of Obligations .  Notwithstanding the termination of this Agreement, the parties to this Agreement shall remain bound by the provisions of this Section 7, which may impose obligations upon the parties that extend beyond the termination of this Agreement.
7.6           “ Restrictive Agreement ” shall mean any agreement between the Company or any Subsidiary and the Optionee that contains non-competition, non-solicitation, non-hire, non-disparagement or confidentiality restrictions applicable to the Optionee.
Section 8.             Corporate Transaction .  The provisions of Section 13 of the Plan shall apply to this Option in the event of a Corporate Transaction.
Section 9.             Miscellaneous .
9.1.             Acknowledgment .  The Optionee hereby acknowledges receipt of a copy of the Plan and agrees to be bound by all the terms and provisions thereof as the same may be amended from time to time.  The Optionee hereby acknowledges that the Optionee has reviewed the Plan and this Agreement and understands the Optionee’s rights and obligations thereunder and hereunder.  The Optionee also acknowledges that the Optionee has been provided with such information concerning the Company, the Plan and this Agreement as the Optionee and the Optionee’s advisors have requested.
9.2.             Reserved .
9.3.             Governing Law; Submission to Jurisdiction; Waiver of Jury Trial .
(a)               Governing Law .  This Agreement shall in all respects be governed by, and construed in accordance with, the laws (excluding conflict of laws rules and principles) of the State of Delaware applicable to agreements made and to be performed entirely within such State, including all matters of construction, validity and performance.
(b)               Submission to Jurisdiction; Waiver of Jury Trial .  Any litigation against any party to this Agreement arising out of or in any way relating to this Agreement shall be brought in any federal or state court located in the State of New York in New York County and each of the parties hereby submits to the exclusive jurisdiction of such courts for the purpose of any such litigation; provided, that a final judgment in any such litigation shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.  Each party irrevocably and unconditionally agrees not to assert (i) any objection which it may ever have to the laying of venue of any such litigation in any federal or state court located in the State of New York in New York County, (ii) any claim that any such litigation brought in any such court has been brought in an inconvenient forum and (iii) any claim that such court does not have jurisdiction with respect to such litigation.  To the extent that service of process by mail is permitted by applicable law, each party irrevocably consents to the service of process in any such litigation in such courts by the mailing of such process by registered or certified mail, postage prepaid, at its address for notices provided for herein.  Each party hereto irrevocably and unconditionally waives any right to a trial by jury and agrees that either of them may file a copy of this paragraph with any court as written evidence of the knowing, voluntary and bargained-for agreement among the parties irrevocably to waive its right to trial by jury in any litigation .
9.4.             Specific Performance .  Each of the parties agrees that any breach of the terms of this Agreement will result in irreparable injury and damage to the other parties, for which there is no adequate remedy at law.  Each of the parties therefore agrees that in the event of a breach or any threat of breach, the other parties shall be entitled to an immediate injunction and restraining order to prevent such breach, threatened breach or continued breach, and/or compelling specific performance of the Agreement, without having to prove the inadequacy of money damages as a remedy or balancing the equities between the parties.  Such remedies shall be in addition to any other remedies (including monetary damages) to which the other parties may be entitled at law or in equity.  Each party hereby waives any requirement for the securing or posting of any bond in connection with any such equitable remedy.
9.5.             Severability .  Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law and if the rights or obligations of any party hereto under this Agreement will not be materially and adversely affected thereby, (a) such provision will be fully severable, (b) this Agreement will be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a part hereof, (c) the remaining provisions of this Agreement will remain in full force and effect and will not be affected by the illegal, invalid or unenforceable provision or by its severance herefrom and (d) in lieu of such illegal, invalid or unenforceable provision, there will be added automatically as a part of this Agreement a legal, valid and enforceable provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible.
9.6.             Notice .  Unless otherwise provided herein, all notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made (a) as of the date delivered, if delivered personally or by email, (b) on the date the delivering party receives confirmation, if delivered by facsimile, (c) three business days after being mailed by registered or certified mail (postage prepaid, return receipt requested) or (d) one business day after being sent by overnight courier (providing proof of delivery), to the parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section): 
(a)   If to the Company:
    Emerald Expositions Events, Inc.
    31910 Del Obispo, Suite 200
    San Juan Capistrano, CA 92675
    Attention:  David Gosling

(b)               If to the Optionee, at the most recent address contained in the Company’s records.
9.7.            Binding Effect; Assignment; Third-Party Beneficiaries .  This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and any of their respective successors, personal representatives and permitted assigns who agree in writing to be bound by the terms hereof.  Neither this Agreement nor any of the rights, interests or obligations hereunder may be assigned by the Optionee without the prior written consent of the Company.
9.8.              Amendments and Waivers .  Subject to applicable law, this Agreement and any of the provisions hereof may be amended, modified, supplemented or cancelled, in whole or in part, prospectively or retroactively, in each case by the Committee; provided that no such action shall adversely affect the Optionee’s material rights under this Agreement without the Optionee’s consent.  The waiver by a party hereto of a breach by another party hereto of any provision of this Agreement shall not operate or be construed as a further or continuing waiver of such breach by such other party or as a waiver of any other or subsequent breach by such other party, except as otherwise explicitly provided for in the writing evidencing such waiver.  Except as otherwise expressly provided herein, no failure on the part of any party to exercise, and no delay in exercising, any right, power or remedy hereunder, or otherwise available in respect hereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such party preclude any other or further exercise thereof or the exercise of any other right, power or remedy.
9.9.              Counterparts .  This Agreement may be executed by .pdf or facsimile signatures and in any number of counterparts with the same effect as if all signatory parties had signed the same document.  All counterparts shall be construed together and shall constitute one and the same instrument.
9.10.           Entire Agreement .  This Agreement and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, oral and written, between the parties hereto with respect to the subject matter hereof.  In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan, the terms of the Plan shall govern.
9.11.            Withholding .  Whenever Option Shares are to be issued upon exercise of the Option, the Company shall have the right to require the Optionee to remit to the Company cash sufficient to satisfy all federal, state and local withholding tax requirements prior to issuance of the shares of Common Stock and the delivery of any certificate or certificates for such shares of Common Stock.  Alternatively, in order to satisfy the withholding tax requirements, the Committee may in its sole discretion permit the Optionee to (x) utilize a broker-assisted "cashless exercise" program, (y) have withheld from the Option Shares otherwise issuable upon exercise of the Option the number of shares having a Fair Market Value equal to the applicable withholding amount in accordance with law (up to the maximum statutory amount) or (z) allow another method or combination of methods under procedures by the Company.  The Optionee agrees to indemnify the Company against any national, federal, state and local withholding taxes for which the Company may be liable in connection with the Optionee’s acquisition, ownership or disposition of any Option Shares.
9.12.          No Right to Continued Employment or Business Relationship .  This Agreement shall not confer upon the Optionee any right with respect to continued employment or a continued business relationship with the Company or any affiliate thereof, nor shall it interfere in any way with the right of the Company or any affiliate thereof to Terminate such Optionee at any time.
9.13.            General Interpretive Principles .  Whenever used in this Agreement, except as otherwise expressly provided or unless the context otherwise requires, any noun or pronoun shall be deemed to include the plural as well as the singular and to cover all genders.  The headings of the sections, paragraphs, subparagraphs, clauses and subclauses of this Agreement are for convenience of reference only and shall not in any way affect the meaning or interpretation of any of the provisions hereof.  Unless otherwise specified, the terms “hereof,” “herein” and similar terms refer to this Agreement as a whole (including the exhibits, schedules and disclosure statements hereto), and references herein to Sections refer to Sections of this Agreement.  Words of inclusion shall not be construed as terms of limitation herein, so that references to “include,” “includes” and “including” shall not be limiting and shall be regarded as references to non-exclusive and non-characterizing illustrations.
[signature page follows]

IN WITNESS WHEREOF, the parties hereto have executed this Agreement, effective as of the Date of Grant.



 
 
 
 
 
EMERALD EXPOSITIONS EVENTS, INC.
           

       
 
 
 
 
 
 
 
 

By:

 
 
 
 
 
 
Name: David Gosling
 
 
 
 
 
 
Title: SVP, General Counsel and Secretary


Agreed and acknowledged as
of the Date of Grant:
_________________________________
Name: Brian Field






Shares Subject to the Option: 1

Option Price:





1 NTD: A number of shares with a Black-Scholes value equal to $105,000 based on the stock price on the Date of Grant, which is expected to be June 3, 2019.

Exhibit A

EMERALD EXPOSITIONS EVENTS, INC.
NOTICE OF OPTION EXERCISE
Subject to the terms and conditions hereof, the undersigned (the “ Purchaser ”) hereby elects to exercise his or her option to purchase __________ shares (the “ Shares ”) of Emerald Expositions Events, Inc. (the “ Company ”) under the Emerald Expositions Events, Inc. 2017 Omnibus Equity Plan (the “ Plan ”) and the Stock Option Agreement dated as of _______________ (the “ Option Agreement ”).  The purchase price for the Shares shall be $______ per Share for a total purchase price of $[●] (subject to applicable withholding taxes).
The Purchaser tenders herewith payment of the full Option Price in the form of (circle applicable method(s)):
(a)   cash, by check or by wire transfer;
(b) wi with permission of the Committee by utilizing a broker-assisted “cashless exercise”; or
(c)   with permission of the Committee, by reducing the number of Shares to be issued to him or her hereby by that number of Shares having an aggregate Fair Market Value on the date hereof equal to the aggregate purchase price of the Shares.
The Purchaser will deliver any other documents that the Company requires in connection with this exercise election.
In connection with the purchase of Shares, Purchaser represents and covenants the following:
1.   Tax Withholding .  The Purchaser authorizes payroll withholding and will make arrangements satisfactory to the Company to pay or provide for any applicable federal, state and local withholding obligations of the Company in connection with the exercise of the Option set forth herein.  The Purchaser may satisfy any federal, state or local tax withholding obligation relating to the exercise of the Option by any of the methods set forth in the Option Agreement.  The Purchaser understands that ownership of the Shares will not be transferred to the Purchaser until the total Option Price and all applicable withholding taxes have been paid.
2.   Knowledge and Representation .  The Purchaser is relying on his or her own business judgment and knowledge and the advice of his or her own counsel, tax advisors and other advisors, regarding the risks of an investment in the Company, in making the decision to purchase the Shares.  The Purchaser, either alone or with his or her advisors, has sufficient knowledge and experience in business and financial matters to evaluate the merits and risks of the purchase of the Shares and has the capacity to protect his or her own interests in connection with such purchase.  In furtherance of the foregoing, the Purchaser represents and warrants that (i) no representation or warranty, express or implied, whether written or oral, as to the financial condition, results of operations, prospects, properties or business of the Company or as to the desirability or value of an investment in the Company has been made to the Purchaser by or on behalf of the Company, and (ii) the Purchaser will continue to bear sole responsibility for making his or her own independent evaluation and monitoring of the risks of his or her investment in the Company.  In addition, the Purchaser understands that he or she is purchasing the Shares pursuant to the terms and conditions of the Plan and the Option Agreement, copies of which the Purchaser has read and understands.
3.   Tax Consequences .  The Purchaser understands that he or she may suffer adverse tax consequences as a result of his or her purchase or disposition of the Shares.  The Purchaser represents that he or she has consulted any tax consultants he or she deems advisable in connection with the purchase or disposition of the Shares and that he or she is not relying on the Company for any tax advice.  Purchaser understands that, prior to the issuance of any Shares, Purchaser will have to make satisfactory arrangements with the Company to satisfy any withholding requirements applicable to the exercise of the Option.


Please record the ownership of such Shares in the name of:
Name:_________________________________________________________________________
Address:_______________________________________________________________________
Social Security or Tax I.D. Number:_________________________________________________


Signature:________________________________________
Dated:______________, 20__



Exhibit 10.4



EMERALD EXPOSITIONS EVENTS, INC.
2017 OMNIBUS EQUITY PLAN

PERFORMANCE BASED SHARE AWARD AGREEMENT

Pursuant to Section 10 of the 2017 Omnibus Equity Plan (the “ Plan ”) of Emerald Expositions Events, Inc. (the “ Company ”), on June 3, 2019 (the “ Grant Date ”), the Company authorized a grant to Brian Field (the “ Recipient ”) of a performance-based share award, subject to the terms and conditions of this agreement between the Company and the Recipient (this “ Agreement ”).  By accepting this award, the Recipient agrees to all of the terms and conditions of this Agreement.  The Company and the Recipient understand and agree that any capitalized terms used herein, if not otherwise defined, shall have the same meanings as in the Plan (the Recipient being referred to in the Plan as a Participant).
1.   Award and Terms . The Company awards to the Recipient under the Plan the right to receive a number of Shares calculated as set forth in Section 1(a) below (the “ Award ”), subject to the restrictions, conditions and limitations set forth in this Agreement and in the Plan, which is incorporated herein by reference. The Recipient acknowledges receipt of a copy of the Plan and acknowledges that the definitive records pertaining to the grant of this Award, and exercises of rights hereunder, shall be retained by the Company.  To the extent the Award remains unvested on the 10 th anniversary of the Grant Date, the Award will be forfeited without any consideration being payable therefor.
(a)   Vesting Dates . Subject to the provisions of this Agreement and the Plan, the Recipient’s right to receive Shares pursuant to this Agreement shall vest based upon achievement of the closing Share prices as set forth in the schedule below (which prices may be adjusted in accordance with Section 12 of the Plan) for a period of at least sixty (60) out of the preceding ninety (90) Trading Days (each such Share price a “ Vesting Threshold ”).  Upon achievement of each relevant Vesting Threshold, subject to Section 1(f), the Recipient shall be issued a number of Shares equal to the corresponding Award Value identified in the schedule below, divided by the closing price per Share on the Trading Day upon which the relevant Vesting Threshold was satisfied.  For the avoidance of doubt, there shall be no ratable vesting for achievement of a closing Share price that falls between the levels stated in the schedule below and in no event shall any individual Vesting Threshold vest more than once.  For purposes of the foregoing, a “ Trading Day ” is any day on which the New York Stock Exchange is open for trading.

60/90 Trading Day Closing Share Price (Vesting Thresholds)
        Award Value
At least $18.00 per Share
$410,000
At least $20.00 per Share
$615,000
At least $22.00 per Share
$820,000
At least $24.00 per Share
$1,025,000
In the event of a Change in Control, if the price per Share paid by the buyer is greater than any of the Vesting Thresholds above (to the extent still unsatisfied), such portion of the Award shall vest upon the closing of such Change in Control by treating such price per Share paid by the buyer as having satisfied the applicable Vesting Threshold(s), and any remaining unvested portion of the Award shall be forfeited as of the closing of such Change in Control.
(b)   Forfeiture of Award on Termination of Employment . If the Recipient Terminates for any reason, the unvested portion of the Award shall terminate. However, if the Recipient’s employment is terminated (i) by the Company or a Subsidiary other than for Cause, or (ii) by the Executive for Good Reason, in either case, within three months prior to the earlier of (x) the date of the execution of a definitive agreement resulting in a Change in Control, or (y) the date of the Change in Control, then any unvested Shares subject to this Awards shall remain eligible to vest in accordance with this Agreement.  Upon a termination for Cause, both the vested and unvested portion of the Award shall be immediately and automatically forfeited for no consideration.  For this purpose, “ Cause ” and “ Good Reason ” have the meanings given to such terms in the Employment Agreement between the Recipient and Emerald Expositions, LLC dated as of May 22, 2019.
(c)   Restrictions on Transfer . The Recipient may not sell, transfer, assign, pledge or otherwise encumber or dispose of the Award other than to the extent permitted by Section 11.2 of the Plan. The Recipient further agrees not to sell, transfer, assign, pledge or otherwise encumber or dispose of any Shares issued upon settlement of any portion of the Award prior to the first to occur of (i) one year following the applicable settlement date, and (ii) the occurrence of a Change in Control.
(d)   No Shareholder Rights . The Recipient shall have no rights as a shareholder with respect to the Award or the Shares underlying the Award until the underlying Shares are issued to the Recipient.
(e)   Delivery Date for the Shares Underlying the Award . As soon as practicable, but in no event later than 15 days following a date on which any portion of the Award vests, the Company will issue to the Recipient the Shares underlying the then-vested portion of the Award, subject to Section 1(f). The Shares will be issued in the Recipient’s name or, in the event of the Recipient’s death after the date of vesting but before the date of delivery, in the name of either (i) the beneficiary designated by the Recipient on a form supplied by the Company or (ii) if the Recipient has not designated a beneficiary, the person or persons establishing rights of ownership by will or under the laws of descent and distribution.
(f)   Taxes and Tax Withholding . The Recipient acknowledges and agrees that no election under Section 83(b) of the Internal Revenue Code of 1986, as amended, can or will be made with respect to the Award. The Recipient acknowledges that on each date that Shares underlying the Award are issued to the Recipient (each, a “ Settlement Date ”), the Fair Market Value on that date of the Shares so issued will be treated as ordinary compensation income for federal and state income and FICA tax purposes, and that the Company will be required to withhold taxes on these income amounts. To satisfy the withholding amount (determined in accordance with applicable law), the Company will withhold from the Shares otherwise issuable upon a Settlement Date a number of Shares having a Fair Market Value equal to the withholding amount (up to the statutory maximum amount) or the Committee may in its sole discretion authorize another method to be utilized under procedures established by the Company.
(g)   Not a Contract of Employment . Nothing in the Plan or this Agreement shall confer upon Recipient any right to be continued in the employment of the Company or any Affiliate, or to interfere in any way with the right of the Company or any parent or subsidiary by whom Recipient is employed to Terminate the Recipient’s employment at any time or for any reason, with or without Cause, or to decrease Recipient’s compensation or benefits.
2.   Prohibited Conduct; Restatements .
(a)   Consequences of Prohibited Conduct . In consideration of and as a condition to the grant of the Award, the Recipient agrees to not engage in Prohibited Conduct (as defined in Section 2(b)). If the Company determines that the Recipient has engaged in any Prohibited Conduct, then the Recipient shall immediately forfeit the Award and shall have no right to receive the underlying Shares.
(b)   Prohibited Conduct . For purposes of this Agreement, Prohibited Conduct means that the Recipient has violated any restrictive covenant contained in the Employment Agreement.
(c)   Restatement of Financial Statements . In addition to the other provisions in this Section 2, this Agreement, the Award and any Shares issued under the Award shall be subject to any policies of the Company in effect on the Grant Date or adopted by the Company at any time thereafter that provide for forfeiture of the Award and recoupment of any Shares issued under the Award or of any gain received by the Recipient in connection with the sale of Shares received in settlement of the Award in the event of any restatement of the Company’s financial statements.
(d)   Determinations . The Committee shall, following a reasonable, good faith investigation, make all determinations regarding this Section 2 in its sole discretion, including whether any Prohibited Conduct has occurred, and the determinations by the Committee shall be final and binding on all parties.
3.   Securities Laws . The obligation of the Company, as applicable, to issue and deliver any Shares hereunder shall be subject to all applicable laws, rules and regulations, and such approvals by governmental agencies as may be required.  The Recipient hereby agrees not to offer, sell or otherwise attempt to dispose of any Shares issued to the Recipient pursuant to this Agreement in any way which would: (x) require the Company to file any registration statement with the Securities and Exchange Commission (or any similar filing under state law or the laws of any other county) or to amend or supplement any such filing or (y) violate or cause the Company to violate the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, or any other Federal, state or local law, or the laws of any other country.
4.   Notices . All notices, consents and other communications required or permitted to be given under or by reason of this Agreement shall be in writing, shall be delivered personally or by e-mail or as described below or by reputable overnight courier, and shall be deemed given on the date on which such delivery is made. If delivered by e-mail or fax, such notices or communications shall be confirmed by a registered or certified letter (return receipt requested), postage prepaid. Any such delivery shall be addressed to the intended recipient at the following addresses (or at such other address for a party as shall be specified by such party by like notice to the other party):
 
To the Company:
Emerald Expositions Events, Inc.
31910 Del Obispo, Suite 200
San Juan Capistrano, CA 92675
Attention: David Gosling
Email: David.Gosling@emeraldexpo.com
     
 
To the Recipient:
At the most recent address or email contained in the Company’s records.
5.   Governing Law; Submission to Jurisdiction; Waiver of Jury Trial .  This Agreement shall in all respects be governed by, and construed in accordance with, the laws (excluding conflict of laws rules and principles) of the State of New York applicable to agreements made and to be performed entirely within such State, including all matters of construction, validity and performance.  Any litigation against any party to this Agreement arising out of or in any way relating to this Agreement shall be brought in any federal or state court located in the State of New York in New York County and each of the parties hereby submits to the exclusive jurisdiction of such courts for the purpose of any such litigation; provided, that a final judgment in any such litigation shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.  Each party irrevocably and unconditionally agrees not to assert (i) any objection which it may ever have to the laying of venue of any such litigation in any federal or state court located in the State of New York in New York County, (ii) any claim that any such litigation brought in any such court has been brought in an inconvenient forum and (iii) any claim that such court does not have jurisdiction with respect to such litigation.  To the extent that service of process by mail is permitted by applicable law, each party irrevocably consents to the service of process in any such litigation in such courts by the mailing of such process by registered or certified mail, postage prepaid, at its address for notices provided for herein.  Each party hereto irrevocably and unconditionally waives any right to a trial by jury and agrees that either of them may file a copy of this paragraph with any court as written evidence of the knowing, voluntary and bargained-for agreement among the parties irrevocably to waive its right to trial by jury in any litigation.
6.   Specific Performance .  Each of the parties agrees that any breach of the terms of this Agreement will result in irreparable injury and damage to the other party, for which there is no adequate remedy at law.  Each of the parties therefore agrees that in the event of a breach or any threat of breach, the other party shall be entitled to an immediate injunction and restraining order to prevent such breach, threatened breach or continued breach, and/or compelling specific performance of the Agreement, without having to prove the inadequacy of money damages as a remedy or balancing the equities between the parties.  Such remedies shall be in addition to any other remedies (including monetary damages) to which the other party may be entitled at law or in equity.  Each party hereby waives any requirement for the securing or posting of any bond in connection with any such equitable remedy.
7.   Binding Effect . This Agreement shall (subject to the provisions of Section 1(d) hereof) be binding upon the heirs, executors, administrators, successors and assigns of the parties hereto.
8.   Severability . Each provision of this Agreement will be treated as a separate and independent clause and unenforceability of any one clause will in no way impact the enforceability of any other clause. Should any of the provisions of this Agreement be found to be unreasonable or invalid by a court of competent jurisdiction, such provision will be enforceable to the maximum extent enforceable by the law of that jurisdiction.
9.   Amendments and Waivers . Subject to applicable law, this Agreement and any of the provisions hereof may be amended, modified, supplemented or cancelled, in whole or in part, prospectively or retroactively, in each case by the Committee; provided that no such action shall adversely affect the Recipient’s material rights under this Agreement without the Recipient’s consent. The waiver by a party hereto of a breach by another party hereto of any provision of this Agreement shall not operate or be construed as a further or continuing waiver of such breach by such other party or as a waiver of any other or subsequent breach by such other party, except as otherwise explicitly provided for in the writing evidencing such waiver. Except as otherwise expressly provided herein, no failure on the part of any party to exercise, and no delay in exercising, any right, power or remedy hereunder, or otherwise available in respect hereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such party preclude any other or further exercise thereof or the exercise of any other right, power or remedy.
10.   Counterparts . This Agreement may be executed by .pdf or facsimile signatures and in any number of counterparts with the same effect as if both signatory parties had signed the same document. Both counterparts shall be construed together and shall constitute one and the same instrument.

[signature page follows]


IN WITNESS WHEREOF, the Company and the Recipient have caused this Agreement to be executed on their behalf, by their duly authorized representatives, all on the day and year first above written.


 
EMERALD EXPOSITIONS EVENTS, INC.
 
       
  By:

 
 
  David Gosling
 
    SVP, General Counsel and Secretary
 



 
RECIPIENT:
 
     
 
 
 
Brian Field
 

[Signature Page to Performance Based Share Award Agreement]
 



Exhibit 99.1

Emerald Expositions Names Brian Field as Chief Operating Officer
SAN JUAN CAPISTRANO, Calif.--(May 22, 2019)-- Emerald Expositions Events, Inc. (NYSE:EEX) (“Emerald” or the “Company”) today announced the appointment of Brian Field as Chief Operating Officer, effective June 1, 2019.
Sally Shankland, Emerald’s newly-appointed Chief Executive Officer, commented, “Brian brings a unique set of skills and experiences to all aspects of the B2B events and marketing services business. He is a collaborative and action-oriented leader with notable strengths in driving change through the application of rigorous execution, technology, and data to the areas of marketing, customer experience,  data-informed product development, operations, data services and sales operations. I was fortunate to work with Brian at UBM and am delighted to have Brian join the Emerald senior leadership team as we strengthen Emerald’s already great assets.”
Mr. Field’s career has spanned more than twenty years, most recently including eight years at UBM, now part of Informa plc, a UK-based multinational events, academic publishing and business intelligence business. For the last five years, Mr. Field was COO of UBM Americas, delivering events and marketing services in the technology, fashion, licensing, advanced manufacturing, construction, healthcare, and pharmaceutical industries. Prior to that role, Mr. Field spent three years at UBM Medica, a leading healthcare media, publishing and education company, where he held senior positions overseeing operations, finance, marketing, product, technology and sales efforts for the business’ print and digital products and events. Earlier in his career, Mr. Field held senior positions in operations, product development, marketing and strategy development at Turner Broadcasting and Omnicom, among others.
Mr. Field holds a bachelor’s degree from Connecticut College, a master’s degree from The Juilliard School, a doctorate from Columbia University, and has recently served on the faculty of the Kogod School of Business at American University.
“Emerald’s portfolio of leading brands covers a wide variety of dynamic market sectors,” said Mr. Field. “I am excited to join the Emerald team to help unlock the significant growth potential of the Company’s assets.”
About Emerald Expositions
Emerald is a leading operator of business-to-business trade shows in the United States. We currently operate more than 55 trade shows, as well as numerous other face-to-face events. In 2018, Emerald’s events connected over 500,000 global attendees and exhibitors and occupied more than 7.0 million net square feet of exhibition space.

Emerald Expositions Events, Inc.
Philip Evans, 1-866-339-4688 (866EEXINVT)
Chief Financial Officer
investor.relations@emeraldexpo.com